header logo image


Page 366«..1020..365366367368..380390..»

What’s Behind All the Pro-Azerbaijan Articles? – Armenian Weekly

October 25th, 2020 5:54 am

Azerbaijans President Ilham Aliyev has opened another battlefront thousands of miles away from Baku, in the pages of local and national newspapers and news sites in the US. Much like the Syrian mercenaries Baku recruited and deployed with the help of Turkish defense contractors to target Armenians, Azerbaijans US-based lobbyists are at the forefront of an information warfare that costs millions of dollars annually.

One important aspect of the work of these lobbyists is to place, disseminate and promote anti-Armenian narratives. Their tactics have evolved into a relentless smear campaign through US media outlets, painting Armenia as a close ally of Iran that undermines Western policies and Armenians as intolerant and anti-Semitic. At the same time, Azerbaijan is depicted as a beacon of tolerance, an ally of Israel and a champion of religious rights.

Bakus lobbyists continually push this narrative by placing articles in various media outlets, reaching out to editors with numerous factsheets and disseminating Baku-approved stories to contacts in positions of power. Many such propaganda pieces that are essentially commissioned by the Azerbaijani government appear in US media outlets without proper disclaimers, and therein loom the danger and deception.

Foreign Agents Registration Act (FARA) filings by Azerbaijans lobbyists show how they approach almost every major outlet from Bloomberg to CNN, the Washington Post, the Jerusalem Post, the New York Times, NBC, Al-Jazeera, San Francisco Chronicle, Sacramento Bee, Haaretz, USA Today, and Wall Street Journal; the list is almost interminably long.

Over the past few weeks, numerous articles have discussed Azerbaijans war on Armenia; many have had a bias, some suspiciously so. It may be impossible to tell which are penned by Aliyevs supporters and which are commissioned or disseminated by Bakus agents here; but a few are (and will be) known because of FARA filings.

From comments left under strikingly pro-Azerbaijani articles, it is clear that many readers have been frustrated and disheartened. Arguably, readers have a right to know whether the content they are consuming is either commissioned or part of a foreign governments information warfare. Without proper disclaimers under articles received from embassies by way of lobbyists, editors risk tarnishing the credibility of the news outlets they represent and deliver a blow to the idea of journalistic integrity. A simple one-liner would suffice, such as, This article was sent to us by [insert name of PR firm] on behalf of the Embassy of the Republic of Azerbaijan to the United States of America. Editors uncomfortable with such disclaimers might reconsider running blatant propaganda pieces that essentially import the state-sponsored narrative of a country with one of the worst media freedom records.

To give readers a clearer idea of how Azerbaijans lobbyists place and disseminate narratives that support Bakus propaganda campaign, I will take a close look at the activities of certain lobbyists employed by Aliyevs government, by examining hundreds of pages of FARA filings available in the US Department of Justice (DOJ) online archives.

An Information Warfare

In an Aug. 25 article titled Russia and Irans Dangerous Energy Gambit in the Caucasus and published by the Begin-Sadat Center for Strategic Studies, human rights lawyer and national security analyst Irina Tsukerman embraces all the talking points put out by Baku. She refers to Artsakh as a fake republic and an ersatz entity. After a series of hypotheticals (like Russia and Armenia might join forces to bring Russian biological weapons close to Azerbaijan), she proceeds to advise Baku on how to handle pro-Armenian sentiment in the west.

Azerbaijan should form a closer joint defense relationship with the US, benefiting from joint training and insights from experienced field operatives and officers. Additionally, greater resources need to be marshalled for information warfare and the political aspect of the battle being waged, including supporting professional media to counter disinformation, building personal and long-term relationships with public officials at all levels, and, most importantly, vigorously pursuing legislative and legal relief in US, European, and international bodies. Armenian officials responsible for human rights abuses should be sanctioned, she writes (italics my own).

Since a large chunk of her article deals with the Armenian National Committee of America (ANCA), which is active in DC, one might understand that Tsukerman is essentially encouraging a foreign government, Azerbaijan, to wage information warfare against a grassroots Armenian-American organization that promotes and advocates for the interests of and issues important to American citizens of Armenian origin. In other words, she is calling on Azerbaijan with its dismal media freedom record to export its relentless propaganda to the US.

In its 2020 report, Freedom House designated Azerbaijan as a consolidated authoritarian regime with a score of 10/100, observing that Constitutional guarantees for press freedom are routinely and systematically violated, as the government works to maintain a tight grip on the information landscape. Defamation remains a criminal offense. Journalists and their relatives face harassment, violence and intimidation by authorities. Many have been detained or imprisoned on fabricated charges, while others face travel bans. Armenia fared as partly free, with a score of 53/100. The report noted Independent and investigative outlets operate relatively freely in Armenia, but their work is generally found online.

We may not know what motivates Tsukermans anti-Armenian rhetoric; she has no known ties to current lobbyists for Baku.

On Oct. 20, another one of Tsukermans articles, co-authored by Jason Epstein, was published by Newsweek. Tsukerman and Epstein unite in [their] support of Sunni-majority Turkeys Shia ally, Azerbaijan, an unabashedly pro-Western country, as it is unfairly smeared. The article argues that the war is not about religion; it discusses Azerbaijans secularism, the Popes 2016 visit to Baku, religious minorities in Azerbaijan, and Ashkenazi, Georgian and Mountain Jews.

No wonder Iran, the largest Shia country in the world but with ethnic Azeris comprising of up to 30 percent of its population, feels threatened by a tolerant Azerbaijans continued geopolitical success and therefore supports Armenia, write the authors. Tsukermans co-author Epstein is the president of Southfive Strategies, LLC and a former public relations consultant for the Turkish Embassy in Washington (2002 2007); he has long considered [himself] both pro-Israel and pro-Turkey. Among Southfives past clients are the Azerbaijan Diplomatic Academy in Baku, the Turkish Embassy in Washington and the Turkish Republic of Northern Cyprus Washington office.

Epsteins work with the Azerbaijan Diplomatic Academy, which is funded by the Azerbaijani government, began on Aug. 1, 2008, when Epstein registered as a foreign agent with the DOJs FARA unit for his work with the Academy. In describing his engagement with that entity, Epstein wrote, Assisting the Academy in producing a policy conference in Azerbaijan on US-Azeri relations, as well as meetings with Azeri officials, business leaders, religious leaders, and media personalities.

When asked whether Southfive would engage in political activities and what those activities might entail, Epstein responded, Encouraging journalists to file stories on US-Azeri relations, based on their experiences at the conference and during various meetings.

The disclaimer under the Newsweek article reads: Jason Epstein is president of Southfive Strategies, LLC, an international public affairs consultancy. Irina Tsukerman is a New York-based human rights lawyer and national security/geopolitical analyst, the vice president of Timberwolf Phoenix, a media and security consultancy, and an adviser to the London-based International Justice Organization. The views expressed in this article are the writers own.

There is no mention of Epsteins past lobbying work for the governments of Azerbaijan and Turkey. A reader would have to independently research Southfive Strategies to learn that for years it had engaged in lobbying on behalf of Azerbaijan and Turkey.

Bakus US Agents

A FARA filing by the Podesta Group in 2013 details the extent of its outreach to US politicians, universities, think tanks, but also most major news outlets, including Bloomberg, Foreign Policy, CNN, Washington Post (and Times), EurasiaNet, Associated Press, USA Today, Wall Street Journal, Jerusalem Post, Al-Jazeera, Los Angeles Times, NBC, New York Times and Haaretz.

Just between June and December of 2017, Podesta received $260,735.56 for its work on behalf of the Azerbaijani Embassy in the U.S., according to a Department of Justice (DOJ) report. That year, Podesta was one of four companies registered with the DOJ for work on behalf of Azerbaijan that cost Baku $560,735.56. During a six-month period that same year, 16 companies worked on behalf of Turkey with a total (reported) price tag of $4,284,020.06. Meanwhile, during the six-month period, an Avedis Boyamian offered pro-bono policy consultation to Armenia; price tag: $0. This information is available in the DOJ report titled, Report of the Attorney General to the Congress of the United States on the Administration of the Foreign Agents Registration Act of 1938, as amended, for the six months ending December 31, 2017.

Among the lobby groups that have represented Azerbaijan in the past couple of years are the Livingston Group (contract terminated on Oct. 13), Stellar Jay Communications, BGR Government Affairs, Sanitas International, Rasky Partners (click here for an earlier and more detailed contract, and here and here for samples of their media outreach), and Baker Donelson (contracted by BGR). Meanwhile, another lobbying firm, S-3 Group, which works on behalf of the Baku-based Investment Corporation owned by Seyidov Tural Oglu, has create[d] and place[d] earned and digital media to further diplomacy between America and Azerbaijan, according to a DOJ filing; for instance, S-3 sent out pro-Azerbaijan factsheets on Oct. 15.

To get an idea of the ties, experience and expertise some of these lobby groups retain, a quick glance at the rank and file of BGR Public Affairs will suffice. Among their team members are: former Governor of Mississippi Haley Barbour; former Policy Director at the Senate Finance Committee Matt Hoffmann; Former Representative Sean Duffy (R-WI); former Senior Executive Clandestine Service Officer with the Central Intelligence Agency (CIA) Daniel Hoffman; former FBI man Tom Locke; former US Ambassador to NATO Kurt Volker; former Director of Legislative Affairs for the National Security Council Mark Tavlarides; former senior USAID official Lester Munson; a Frank Ahrens who can arrange client interviews with Fox News, CNN, The Washington Post and major wire services; and a Jeff Birnbaum who is a former White House, congressional and tax reporter for the Wall Street Journal, a senior political correspondent for Time Magazine, Washington bureau chief for Fortune Magazine and a columnist for the Washington Post.

When Azerbaijan and Turkey pay millions to employ such lobbying firms, they are in effect buying ease of access to major national news services.

A Stellar Case

The case of one public relations firm employed by Baku might offer a glimpse into the Azeri lobbying efforts through pro-Azerbaijan articles in US media. The articles pushed on various editors deal with that general theme of tolerant Azerbaijan and intolerant Armenia. Whatever information warfare Tsukerman might have been alluding to in her article is displayed below.

At the center of the story is Jacob Kamaras, the former editor-in-chief of the Jewish National Syndicate (JNS), where pro-Azerbaijan and anti-Armenian articles have appeared in the past two years (for instance, Irina Tsukermans Oct. 12 article), including pieces that promote denial of the Armenian Genocide. Kamaras is the founder and chief of Stellar Jay Communications, which actively lobbied for the Azerbaijani Embassy in the US in 2020, and about which Julian Pecquet, founder and editor of the Foreign Lobby Report, has written. Note that Kamaras has filed a Fictitious Business Name Statement for his company with the DOJ.

Kamaras registered to lobby for the Azerbaijani Embassy on Jan. 31, 2020. The DOJ form informs that the registrant engages with Azerbaijans Ambassador Elin Suleymanov and receives a $3,300 fee per project. Kamaras principal mode of operation is through outreach to newspapers and editors, as noted in another DOJ file. Still another DOJ filing reveals that Kamaras, whose work for the Embassy entailed media consulting and op-ed placement, was paid $56,100 between Feb. 17 and July 10, 2020, presumably for 17 projects.

Among the papers Kamaras submitted to the DOJ are a number of emails he sent to news outlets, urging them to publish certain pro-Azerbaijan articles and offering certain pro-Azerbaijan talking points. There are 14 files (excluding the companys registration) that span the first eight months of the year; the last disclosure is dated August 7.

Propaganda: Israel Should Ally with Tolerant Azerbaijan

In the first email dated Feb. 12, addressed to the editors at the conservative CNSNews.com, Kamaras asks the news website to consider publishing an article by Maayan Hoffman, the news editor at The Jerusalem Post, titled, A Jewish-Muslim paradigm for peace. Hoffman argues that Azerbaijan has pioneered a paradigm for warm Muslim ties with Israel, the nation Tehran repeatedly vows to wipe off the map Israel only stands to benefit from having an ally like Azerbaijan on the border of arguably the Jewish states fiercest enemy. She stresses that Jews live in Azerbaijan in peace and prosperity and details various developments in the benevolent attitude of Baku towards its Jewish minority population.

Kamaras email (like all his other emails discussed below) ends with a disclaimer noting that the email and its contents are sent by Stellar Jay Communications on behalf of the Azerbaijani Embassy.

On Feb. 13, CNSNews published the story, slightly altering the headline to read, Heres What a Jewish-Muslim Paradigm for Peace Looks Like. A brief bio of the author appeared below the article: Maayan Hoffman is news editor and head of online content and strategy at The Jerusalem Post. She has been an American-Israeli international journalist for more than two decades. There was no mention of Stellar Jay Communications or the Azerbaijani Embassy.

Propaganda: Armenia is Anti-Semitic

Kamaras second email dated March 9 is addressed to Rob Shimshock of CNSNews, containing yet another article, this time by Jesse Bogner and titled The old anti-Semitism is alive and well. This piece alleges that there is medieval-style anti-Semitism coming from Armenian organizations and commentators, and that [T]he ANCAs recent rhetoric on Twitter represents the latest indicator of not only the anti-Semitism emanating from Armenia, one of the worlds oldest Christian nations, but also of the disturbing perpetuation of classical Christian anti-Semitism. Of course, Bogner portrays Azerbaijan as a haven of tolerance. By contrast, Armenias Muslim-majority neighbor has a deep relationship with Israel, no history of anti-Semitism, and a prosperous Jewish community of its own for more than two millennia, he writes.

Apparently CNSNews did not publish Bogners article. On March 15, the piece was published on Bogners blog on The Times of Israel. Again, there was no mention of the Azerbaijani Embassy; just Bogners bio: Jesse Bogner is an author and journalist. His memoir and social critique, The Egotist, has been translated into five languages. His work has been featured in The Daily Caller, MSN, The Daily Wire and The Huffington Post. His book of articles, Tikkunim (Corrections), was released in January 2018.

It is outside the scope of this article to counter such propaganda. However, I will refer you to Yoav Loeffs Jan. 27 article titled, Armenias Antisemitism? The Truth Is Different, in The Jerusalem Post, which he wrote coincidentally in response to a piece by Hoffmanthe same Hoffman whose articles Kamaras disseminated on behalf of Azerbaijans Embassy. Loeff, who teaches Armenian history and culture at the Hebrew University of Jerusalem, is Jewish and has traveled to Armenia with other Jews and Israelis on many occasions, and stresses that he has never heard a hint of antisemitic expression.

If there is some criticism, it is usually about Israels hesitation to recognize the Armenian genocide that was perpetrated by the Ottoman Empire he writes.

Armenias small Jewish community never suffered antisemitism in their adopted homeland. Most of them left in the early 1990s, after the severe earthquake in the north of the country in 1988 and the collapse of the Soviet Union, explains Loeff. He notes the dire economic situation following the earthquake and the Artsakh war and adds, They did not leave because they faced any antisemitism; they left because they sought better life.

Loeff also discusses the various ways in which Armenian government representatives had honored Holocaust victims, from Armenian President Armen Sarkissians attendance at the World Holocaust Forum in Jerusalem to the erection of a monument in Yerevan in memory of the victims of the Holocaust and the Armenian Genocide. Unfortunately, there is no parallel such monument in Israel, he adds.

Propaganda: Azerbaijan is a Friend to Israel

On March 13, Kamaras emailed The Jewish Voice editor Fern Sidman, offering him a piece by Hoffman, this time titled, Could fighting coronavirus be the latest frontier in the Israel-Azerbaijan relationship? Hoffman noted the presence of Azerbaijans Finance Minister Samir Shafirov at the AIPAC Policy Conference and quoted him to have said, Cooperation with Israel is not limited to oil supply; we are interested in widening cooperation in defense and the transfer of technology. Apparently Shafirov also read Azerbaijans first-lady-turned-vice-president Mehriban Aliyevas remarks praising Azerbaijani-Jewish ties in the US. The gist of the article was the importance of strengthening Azerbaijani-Israeli ties. The email closed with the usual disclaimer about Kamaras communicating on behalf of the Azerbaijani Embassy.

Hoffmans piece was accepted and published without any mention of Kamaras firm or the Azerbaijani Embassy. However, some days later, NBC news published a piece highlighting Hoffmans article as an example of foreign governments using American lobbyists to promote their efforts to fight the coronavirus outbreak and safeguard their countries reputations in the U.S. capital. NBC goes on to point out that The piece was written by Maayan Hoffman, identified as a Jerusalem Post news editor, but the published version makes no mention that the commentary was placed by Stellar Jay Communications, a lobbying firm representing the government of Azerbaijan, as a FARA filing shows.

NBC was right about foreign governments promoting their countries, safeguarding their reputations and placing op-eds in various papers. What NBC failed to understand is that this was not about the coronavirus, but part of an information war that ultimately feeds and bolsters the myth of the religiously tolerant Azerbaijan and the intolerant Armenia; and that is one of the key objectives of Baku, and by extension their US agents.

Propaganda: Armenia is a Friend to Iran

On April 23, Kamaras sent out another email to CNSNews with an article written by Bogner, whoin Kamaras wordsexamines how the coronavirus is not stopping Iran from fueling conflict and undermining sanctions through its proxies. Specifically, he looks at Armenias role in empowering Iran economically. The article, titled, Coronavirus doesnt stop Iran from fueling the fire of conflict, accuses Iranian trucks of delivering fuel to Nagorno-Karabakh, the Armenian-occupied region which several U.N. resolutions affirm as part of Azerbaijan, charges Armenian banks of enabling Tehran, and faults Democratic US lawmakers for having a pro-Armenian policy agenda.

The article ignores Azerbaijans ties with Iran, the fact that in 2019 Azerbaijans imports from Iran were worth US $452.63 million and exports at US $41.13 million, while Armenias imports from Iran were worth US $324.7 million and exports at US $83.84 million, according to the United Nations COMTRADE database. In other words, both countries maintain an economic relationship with their sanctioned neighbor.

Once again, Bogners piece did not appear in CNSNews and instead was published on his blog on the Times of Israel without any mention of the Azerbaijani Embassy or Jay Stellar Communications.

Propaganda: Azerbaijan Champions Religious Freedom

Kamaras next email (May 6) was also to CNSNews, in which it becomes clear that Rob Shimshock (the recipient) did not respond to the lobbyists previous two emails (which also explains why Bogners pieces ended up on his blog). This time, Kamaras submits his own article titled Azerbaijans postponed Formula 1 race transcends sports about which he tells Shimshock, I write that despite the events postponement this year, the annual Formula 1 auto race hosted by Muslim-majority Azerbaijan particularly during the Islamic holy month of Ramadan is a powerful display of religious freedom, especially in a world plagued by sectarian conflict and now by the invisible enemy of the coronavirus.

What Kamaras fails to mention is that Freedom House gave Azerbaijan a score of 0 out 4 for religious freedom in its 2020 report, which noted, The regime exercises control over religion through state-affiliated entities such as the Caucasus Muslim Board. Religious communities that attempt to operate independently face burdensome registration requirements, interference with the importation and distribution of printed religious materials, and arrest and harassment of religious leaders with international ties or a significant following. In other words, the idea of a religiously tolerant Azerbaijan is a myth nurtured by Bakus agents abroad.

In any case, at the end of the article submission, Kamaras includes his bio: Jacob Kamaras, former editor in chief of the Jewish News Syndicate, is noted for his work on the Middle East and American politics. His writing has appeared in the Washington Times, Independent Journal Review, the American Spectator, and various Jewish and Israeli media. It makes no mention of his role as a lobbyist on behalf of the Embassy of Azerbaijan to the US. However, the email does end with the usual disclaimer.

CNSNews published the article on May 7, slightly altering the title to read, Azerbaijans Grand Prix Transcends Sports, Speaks to Religious Freedom. However, it added the following to Kamaras bio: Jacob Kamaras is founder of Stellar Jay Communications, a PR firm representing Azerbaijan. The next day, another lobbyist on behalf of Azerbaijan, Mark Tavlarides of the BGR Group, emailed the article out to relevant contacts, urging them to read it.

Propaganda: Israel and Azerbaijan are Partners (and Trailblazers in the Understanding of Aging)

A few days later, Kamaras reached out to the editor of the Salinas Californian, Silas Lyons, with a story written by Diana Cohen Altman, former executive director of the Karabakh Foundation and a contributor to the JNS. Altmans piece was about Azerbaijanis who live up to 120 years old in Lankaran. Altman discusses diet, genetics and clusters of very old people in Azerbaijan, as well as longevity in Ashkenazi Jewish populations. Quoted in the piece is a surgeon who is a member of the Azerbaijan-Israel Inter-Parliamentary Work Group. The piece concludes with yet another nod to Azerbaijani-Israeli friendship with these words: Azerbaijan has fostered significant partnerships in the humanities and other disciplines, and the West is building an understanding of Azerbaijani culture and contributions. Amid the pandemic and in the coming years, the U.S. scientific community may look to Israel and Azerbaijan who are partners in technical and other arenas for breakthroughs in the understanding of aging.

The piece did not appear in The Californian. Instead, it was published by The Jerusalem Post on June 4. The final paragraphs were altered a bit, and there was this addition: The Azerbaijani superaging phenomenon may also be of particular interest to social scientists, given major societal changes during the past century. Consider this: Someone over the age of 100 might have witnessed what is now the Republic of Azerbaijan as a portion of the Russian Empire, a part of the early Azerbaijani Democratic Republic, and as an S.S.R. of the Soviet Union. In effect, this addition attempts to insert a historical footnote in this article that on the surface appears to be about longevity.

Altmans bio appears at the end of the piece: Diana Cohen Altman, principal of Cultural Diplomacy Associates, L.L.C., and former executive director of the US cultural non-profit Karabakh Foundation, writes extensively about Azerbaijani cultural and civil-society topics. It made no mention of the Embassy of Azerbaijan or Jay Stellar Communications. Also to note, Altman is still listed on the Karabakh Foundations website as its Executive Director.

Propaganda: Armenians are Intolerant, Anti-Semitic

On June 11, through Kamaras, Baku resorted again to charges of anti-Semitism as a desperate attempt to vilify Armenian Americans. An email informs that Kamaras own article appeared in BreakingIsraelNews (Israel365News.com), titled Armenias Self-Defeating Campaign Against Christians. The article ran as an op-ed. It decried Armenian-American opposition to evangelical pastor Rev. Johnnie Moores support of Azerbaijan and Trumps Middle East policies, singled out Asbarez news for its coverage and bashed the ANCA, accusing it of anti-Semitic tweets.

Although at the base of his email, Kamaras included his disclaimerThis material is distributed by Stellar Jay Communications on behalf of the Embassy of the Republic of Azerbaijan to the United States of Americathe published article made no mention of the authors bio or of his work on behalf of the Azerbaijani Embassy. Readers were (and continue to be) misled into believing the piece was written by a concerned writer and not a paid agent of Azerbaijans propaganda campaign. The Azerbaijani news.az reprinted the article, also without any mention of Kamaras role as a foreign agent for Baku.

Propaganda: Armenia is an Occupier; Unreliable Partner; Aids Iran

On July 14, Kamaras approached The Washington Free Beacon with a list of Azerbaijani talking points on the escalation of violence between Armenia and Azerbaijan. I wanted to share a few angles below that could help you provide broader context in any story, if you choose to pursue one. Should you want to set up a phone interview with the ambassador, please let me know and Ill be happy to arrange it, wrote Kamaras. The Beacon did not take him up on the offer. In fact their last report that even mentions Azerbaijan ran in January of this year. Nonetheless, its worth reviewing Kamaras talking points.

Aside from highlighting some European support for Azerbaijans territorial integrity, Kamaras shared an article by none other than Bogner in American Thinker titled, Democrats West Bank rhetoric rings hollow, in which the author asks, Where is the condemnation of Armenias occupation of the same percentage of internationally recognized Azerbaijani territory, in the Nagorno-Karabakh region?; another article by Paul Miller in the JNS titled, Beware of the sanctions busters, accuses Armenia of offering the [Iranian] mullahs one of their best escape routes from crippling American sanctions; as well as Hoffmans article in BreakingIsraelNews titled, A Nation that is Faithful to Iran Is no Reliable Partner (one can glean the spirit of the article from the title). He also shared a July 7 article in Arab News by Iranian American journalist Adelle Nazarian, a foreign policy analyst with Breitbart News who was in Azerbaijan in 2019. In it, Nazarian argues that Now is the time for US lawmakers to echo Europes support for territorial integrity. Hypocrisy should no longer be accepted.

Propaganda: Armenians are Plagued by Extremist Ideologies(Like Nazism and Anti-Semitism)

On July 13, Kamaras emailed Fox News correspondent Hollie McKay, offering her the opportunity to interview Azerbaijans Ambassador to the US Elin Suleymanov. McKay had interviewed the Ambassador in March 2019. She did not interview the Ambassador in July, but Fox News did speak with him on Sept. 28, just as Azerbaijan launched its offensive. (On Oct. 4 McKay did report on the recruitment of Syrian fighters by Turkish defense contractors to fight in Azerbaijan).

In early August, Kamaras approached a number of news sites on behalf of Amb. Suleymanov. On Aug. 5, he emailed Mercury News asking them to publish an article penned by the Ambassador, titled Hate crimes have no place under the California sun.

The Ambassadors article centers on a scuffle between Armenian and Azerbaijani protesters in Los Angeles. He proceeds to highlight some statements from Jewish American groups regarding the incident and suddenly hurls allegations of anti-Semitism. Both Armenia and the Armenian communities abroad have long been plagued by extremist ideologies, political violence and a complicated history with anti-Semitism, Nazi collaborators and Middle Eastern radicals, he writes.

Such broad charges are not only insulting to Armenians worldwide and Armenian Americans, many of whom fought the Nazis, but also warps history, erasing the sacrifices of many like the members of the Manouchian Group, one of the most active French resistance groups. Of course, this is coming from the representative of a government that wholeheartedly joins neighbor Turkey in its unashamed and continued denial of the genocide perpetrated by its Ottoman Turkish predecessor.

Essentially, the Ambassador is relying on charges of anti-Semitism against Armenians to draw support for the Azerbaijani policies and claims against Artsakh. By doing so, he is using the very real presence and danger of anti-Semitism in the world as a tool to further Bakus agenda and in the hopes of garnering Jewish American and Israeli sympathies. As Kamaras previous emails show, Bakus tactics have at their core the manipulation of fears towards both Iran and anti-Semitism.

The Ambassadors article was presumably rejected by Mercury News, because on Aug. 6 Kamaras submitted the same piece to the San Francisco Chronicle. Three minutes later, he sent the piece to The Sacramento Bee; and a minute later to The Hill. The article was finally published in The Monterey County Herald on Aug. 12, despite its overt propagandizing and vilification of Armenians worldwide.

That is the last of Kamaras activities submitted to the DOJ.

A Glance at BGR

Other lobby groups, such as BGR, also heavily publicized pro-Azerbaijan viewpoints and articles, and reached out to various media outlets for interviews, or to offer talking points. For instance, the DOJ FARA registration unit received a copy of an email from Mark Tavlarides of the BGR Group, which shared an article by the same Nazarian, titled, Azerbaijan: A Nation that Bears the Torch, and Burden, of Bringing Religious Freedom to its Less Tolerant Neighbours in the Region.

The author, Adelle Nazarian, visited Azerbaijans 5th World Forum on Intercultural Dialogue in Baku. Nazarian noted the insightful meetings and visits which left her acutely aware of the sensitive nature of Azerbaijans position as a potential kingmaker for the cause of religious freedom and unity between the three Abrahamic faiths in the region. She expressed hope that religious freedom would also flourish in Azerbaijans neighbors in the region, wrote Tavlarides in his email.

Tavlarides has on many occasions disseminated pro-Azerbaijan articles on behalf of the Embassy, such as a piece by Hoffman in the JNS, titled Azerbaijani national hero provides a paradigm for Jewish-Muslim relations. On numerous other instances, Tavlarides sent out the links to articles, official Azerbaijani statements, resources, factsheets (including an Oct. 5 email), press releases, the pro-Azerbaijan statements of various organizations and politicians, and tweets such as one sent out by Israels Ambassador to the US touting Azerbaijan as a beacon of religious tolerance, as well as another one by Luke Coffey, director of Foreign Policy Studies at The Heritage Foundation, critical of Armenia and Armenians.

In a turn from the cynical to the absurd, Tavlarides also disseminated a link to an episode of the CBS show Seal Team, which depicts the fictional support of elite US forces to help protect an Azerbaijani power plant from a potential attack by Armenian loyalists, Shiite militia, or foreign powers looking to reduce American influence in the region. Tavlarides went on to stress that The scene emphasizes the strategic role of Azerbaijan as our only ally in the Caspian Sea and a deterrent to unaligned powers in the area.

Azerbaijan paid BGR $510,000 in 2019, $600,000 in 2018, and $490,000 in 2017.

The Case of Brenda Shaffer

In 2015, Till Bruckner of the Organized Crime and Corruption Reporting Project (OCCRP) published a piece titled, How to Build Yourself a Stealth Lobbyist, Azerbaijani Style. The focus of the article is Brenda Shaffer, a visiting researcher and adjunct professor at Georgetown University, a Senior Fellow at the Atlantic Councils Global Energy Center, professor at the University of Haifa, and former head of the Caspian Studies Program at Harvard, which was funded by the Azerbaijan Chamber of Commerce. Bruckner discusses Shaffers various activities and lays out her myriad connections with Azerbaijans lobbyists, including her role as adviser to the State Oil Company of the Azerbaijan Republic (SOCAR).

According to Bruckner, Shaffers activities included testifying before the House of Representatives Committee on International Relations, contributing to various DC think tanks (including a panel discussion on Azerbaijan, hosted by the Carnegie Endowment for International Peace, during which she reportedly praised the countrys vibrant press), and writing numerous op-eds for US and Israeli news outlets. She was often consulted on matters relating to Azerbaijanwhether by the media or US officials.

Supported by an overseas regime and an assorted network of overt and undercover lobbyists, she used oil money to build her academic credentials, then in turn used those credentials to promote Azerbaijans agendas through Congressional testimony, dozens of newspaper op-eds and media appearances, countless think tank events, and even scholarly publications, wrote Bruckner.

In a 2006 Harpers Magazine piece titled Academics for Hire, journalist Ken Silverstein wrote, Caspian watchers beware: the next time you see or hear an independent American expert talking about how the regions rulers are implementing bold reforms, check the experts credentials to see just how independent he or she truly is.

After inquiries by Bruckner, some newspapers like The New York Times and The Washington Post added disclaimers under Shaffers articles, disclosing her roles and ties to SOCAR. Others did not.

Shaffer continues to publish op-eds on the subject. For instance, on Oct. 14, JNS ran a piece by Sean Savage titled, How the Armenian-Azerbaijani conflict could impact Israels regional strategic landscape.

Israel and Azerbaijan maintain a strategic alliance. It is not just about arms sales or oil, but a very deep strategic cooperation, she told JNS, adding, Israel has friendly ties with the Armenian people and is home to a vibrant Armenian community. On strategic issues, however, the two states are on different sides. Armenia has close cooperation with Iran, and much of the military supplies to Armenia today transit Iranian territory.

Shaffers credentials were left as a senior fellow at the Atlantic Councils Global Energy Center. The JNS piece was reprinted in multiple outlets.

Armenian Americans Fight Back

The ANCA, the Armenian Assembly and many concerned Armenian Americans have been vocal with their efforts to pressure lobbyists to back down and terminate their contracts, as Foreign Lobbys Pecquet reports. Already over the weekend, the Armenian diaspora bombarded the S-3 Group with more than a thousand emails with an identical message pressuring the Washington public affairs firm to stop representing a new client from Azerbaijan (Foreign Lobby Report was copied on the emails), wrote Pecquet, adding, The firm recently picked up a Baku-based company called Investment Corporation, LLC for $25,000 per month to create and place earned and digital media to further diplomacy. The diaspora letter, which you can read in its entirety here, describes S-3s client as a thinly veiled front for the Government of Azerbaijan through a proxy shell corporation.

Their aim is to vilify Armenians worldwide.

The Livingston Group terminated its contract with the government of Azerbaijan on Oct. 13. Pecquet notes that this came three months after the lobby group informed the DOJ that it was negotiating another contract with Baku. Pecquet also reported that DLA Piper, a lobby group working for the state-owned Azerbaijan Railways CJSC, terminated its contract on Oct. 19. DLA Piper was contracted to provide the foreign principal with legal advice and assistance relating to U.S. sanctions on Iran that affect the transport of oil, gas, and other petrochemical products that originate in third countries and that transit through Iran.

Meanwhile, the lobbying firm Mercury Public Affairs cut its ties with Turkey on Oct. 23, after pressure from the Armenian American community. The decision came following protests led by the ANCA and the Armenian Assembly outside the firms offices, as well as pressure from current clients like Los Angeles County, California State Assembly, and Los Angeles Community College District representatives, reported Politico.

A lot of people have bought a lot of summer homes and fishing boats and put their grandkids through college by lying about Armenia and covering up for Azerbaijan, ANCA Executive Director Aram Hamparian told Politico.

Hamparian said that BGR was next on the list.

Fact: Baku Aims to Vilify Armenians through US Media

Some of the articles disseminated by these lobby groups employed by Azerbaijan cross-link with others written by authors like Bogner, desperately trying to paint Armenia as a threat like Iran, and Armenians as anti-Semites. Reading these articles, one might not even realize that there is a Jewish community in Armenia as well, and they too have spoken up (See Lara Setrakians article in Haaretz titled, Im Jewish and Armenian. Israeli Weapons Are Killing My People). Their existence is not weaponized in western media by either Armenians or the Armenian government.

In all this, it is clear that Azerbaijans smear campaign against Armenia relies on those two tales: Armenia is dangerous; and Armenians are intolerant and anti-Semitic. The basic calculations run something like this: Israel is good; Iran is bad; Armenia is to Azerbaijan what Iran is to Israel; therefore, Armenia must be bad, and Azerbaijan must be good; and furthermore, Israel and Azerbaijan must stand united, while Iran and Armenia are the enemy and must be sanctioned. These are the points that are being pushed by Bakus lobbyists to elicit an unfavorable public perception of Armenia and Armenians. Their aim is to vilify Armenians worldwide. The sheer number of articles pushing this narrative is astounding. Some of them are paid for and disseminated by Azerbaijans lobbyists, and published without any disclaimers to highlight that fact. The propaganda is so blatant that one wonders how anyonewhether readers or editorscould take any of these pieces seriously.

However, the responsibility to vet and flag such articles falls squarely at the feet of editors. By publishing articles without the appropriate scrutiny and disclaimers, editors are complicit in the disinformation campaign and agents of Bakus information war. Mercenaries and lobbyists are motivated by Aliyevs petro-dollars. One can only hope that editors are driven by the pursuit of truth; and those who are not should consider sending their resumes to the Azerbaijani Embassy in DC.

Authors note: Id like to thank Khatchig Mouradian for his feedback. This article does not deal with the activities of lobby groups working on behalf of Turkey, or the financial contributions of Azerbaijans lobby groups to US politicians running for office, or other activities and outreach efforts (such as the Oct. 2 Zoom session with Amb. Suleymanov and congressional staff hosted by BGR), as they are outside the scope of this piece. Those interested can read more about Azerbaijans lobbying efforts at Opensecrets.org, a website that tracks developments in the shady lobbying world.

Nanore Barsoumian was the editor of the Armenian Weekly from 2014 to 2016. She served as assistant editor of the Armenian Weekly from 2010 to 2014. Her writings focus on human rights, politics, poverty, and environmental and gender issues. She has reported from Armenia, Nagorno-Karabagh, Javakhk and Turkey. She earned her B.A. degree in Political Science and English and her M.A. in Conflict Resolution from the University of Massachusetts (Boston).

Continued here:
What's Behind All the Pro-Azerbaijan Articles? - Armenian Weekly

Read More...

Global Precision Medicine Software Market (COVID-19 Analysis) Industry Share, Growth, Trends Analysis Report 2020-26 – The Think Curiouser

October 25th, 2020 5:54 am

In the latest Research Report onGlobalPrecision Medicine Software Market offers an Exclusive Research analysis of the present scenario of the global market.This report contains market revenue, sales, Precision Medicine Software production and manufacturing cost that could help you to get a better view on the market. The Report Focuses on the key global Precision Medicine Software industry manufacturers to describe and analyze the sales volume, value, market share, market competition landscape withSWOTanalysis and development plans in next few years.Major parameters covered under these company profiles include revenues, gross profits, operating income,COGS, EBITDA, sales volume, product offerings, company landscape analysis, key strategic moves, key recent developments, and technological roadmap.Syndicatemarketresearch providesa complete understanding of general market scenarios and future market situations to prepare for rising above the challenges and ensuring strong growth,the complete analysis of Precision Medicine Software Market Size, Data and development forecast from 2020-2026.

Download FREE Sample Report here:-https://www.syndicatemarketresearch.com/sample/precision-medicine-software-market

(We Provide Free Sample copy as per your Research Requirement, also including COVID 19 impact analysis)

The Major Manufactures covered in this Report:-Syapse, Allscripts, Qiagen, Roper Technologies, Fabric Genomics, Foundation Medicine, Sophia Genetics, PierianDx, Human Longevity, Translational Software, Gene42 Inc, Lifeomic Health

Global Precision Medicine Software Market Product and Application Are:-

Product:Cloud-based, On-premises

Application:Healthcare Providers, Pharmaceutical and Biotechnology Companies, Research Centers and Government Institutes, Other

Syndicatemarketresearch analysts covers all key parameters required for COVID-19 effect on business industry, economic implications their trends, factors, consumer behavior on shopping, effect on spending lot of money on advertising and also on useful industries like medical, transportation, food and Beverage.The globally rising of Bio crisis COVID-19 has many businesses are struggling and confused on what steps to take to minimize or maximize the economic impact.

The Global Precision Medicine Software Market Research Report Forecast2020-2026is a valuable source of insightful data for business strategists. It provides the Precision Medicine Software industry overview with growth analysis, historical & futuristic cost, revenue, demand and supply data. The research analysts provide an elaborate description of the value chain and its distributor analysis. This Precision Medicine Software market study provides comprehensive data which enhances the understanding scope and application of this report.

Geographically, Global Precision Medicine Software Market covers:-United States, Europe, China, Japan, India and Southeast Asia and rest of the world

(Our Analystcan add Regional analysis as per your Research need also)

Timeline for Analysis:-

Key Stakeholders

To Get Depth Knowledge about Precision Medicine Software Market Report, Enquiry here:-https://www.syndicatemarketresearch.com/inquiry/precision-medicine-software-market

Key questions answered in this report

The study objectives of this report are:-

Syndicate Market Research provides customization of reports as per your need. The report can be altered to meet your requirements. Contact our sales team, who will guarantee you to get a report that suits your needs.

If you have any special requirements, please let us know and we will offer you the report as you want.

View Customized Full [emailprotected]https://www.syndicatemarketresearch.com/market-analysis/precision-medicine-software-market.html

Read other Report:-https://www.openpr.com/news/2160425/global-blockchain-technology-in-healthcare-covid-19

Contact US:

Syndicate Market Research244 Fifth Avenue, Suite N202New York, 10001, United StatesEmail ID:[emailprotected]Website:https://www.syndicatemarketresearch.com/Blog:Syndicate Market Research Blog

See the article here:
Global Precision Medicine Software Market (COVID-19 Analysis) Industry Share, Growth, Trends Analysis Report 2020-26 - The Think Curiouser

Read More...

AI Medicine Software Industry Market Outlook | Development Factors, Latest Opportunities and Forecast 2025 – The Think Curiouser

October 25th, 2020 5:54 am

Market Study Report, LLC, provides a research on the AI Medicine Software Industry market which offers a concise summary pertaining to industry valuation, SWOT Analysis, market size, revenue estimation and geographical outlook of the business vertical. The study descriptively draws out the competitive backdrop of eminent players driving the AI Medicine Software Industry market, including their product offerings and growth plans.

The latest research report on the AI Medicine Software Industry market assesses the major factors influencing industry growth with respect to the competitive dynamics and geographical reach. It also ensembles the challenges prevalent in this industry vertical and identifies opportunities that will further aid business expansion. Further, the report revisits all areas of the business to cover the impact of COVID-19 pandemic so as to assist stakeholders in devising new strategies and reinforcing their position in the market.

Request a sample Report of AI Medicine Software Industry Market at:https://www.marketstudyreport.com/request-a-sample/2767819?utm_source=thinkcuriouser.com&utm_medium=SK

Key pointers from COVID-19 impact analysis:

Important inclusions in the AI Medicine Software Industry market report:

Ask for Discount on AI Medicine Software Industry Market Report at:https://www.marketstudyreport.com/check-for-discount/2767819?utm_source=thinkcuriouser.com&utm_medium=SK

Regional scope:

TOC of AI Medicine Software Industry Market Report Includes:

The Report Answers the key Questions

For More Details On this Report: https://www.marketstudyreport.com/reports/covid-19-outbreak-global-ai-medicine-software-industry-market-report-development-trends-threats-opportunities-and-competitive-landscape-in-2020

Related Reports:

1. Global Wearable Payment Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)Read More: https://www.marketstudyreport.com/reports/global-wearable-payment-market-report-2020-by-key-players-types-applications-countries-market-size-forecast-to-2026-based-on-2020-covid-19-worldwide-spread

2. Global Home Design Software Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)Read More: https://www.marketstudyreport.com/reports/global-home-design-software-market-report-2020-by-key-players-types-applications-countries-market-size-forecast-to-2026-based-on-2020-covid-19-worldwide-spread

Related Report : https://www.marketwatch.com/press-release/global-multi-screen-content-discovery-engines-market-to-show-strong-growth-at-cagr-of-271-by-2025-2020-10-22

Contact Us:Corporate Sales,Market Study Report LLCPhone: 1-302-273-0910Toll Free: 1-866-764-2150 Email: [emailprotected]

Read more from the original source:
AI Medicine Software Industry Market Outlook | Development Factors, Latest Opportunities and Forecast 2025 - The Think Curiouser

Read More...

Flint children exposed to lead suffer from dental problems, learning disabilities, other issues – MLive.com

October 25th, 2020 5:54 am

FLINT, MI Dachelle McDonalds 10-year-old daughter has had numerous dental visits, a dental operation and teeth that seemed to practically fall out of her mouth without any effort.

McDonald isnt entirely sure any of those issues are related to lead exposure, but her daughter, Neveah Dixon, was drinking the lead-poisoned water just like many others six years ago when Flint changed its water source from treated Detroit Water and Sewerage Department water to the Flint River.

She could just pull her teeth out of her mouth when they started getting loose, McDonald said. It was just weird the way her teeth fell out her mouth.

McDonald remembers her daughter as having issues with her teeth for as long as shes had them.

Her teeth - she always has teeth problems, were always at the dentist, McDonald said. Her skin has two-tone on her face, which is weird because no one in my family, no one has skin like that.

In Flint during the water crisis, the percentage of children with elevated blood lead levels nearly doubled citywide, and nearly tripled among children in high risk areas of lead exposure, according to research by Dr. Mona Hanna-Attisha, the pediatrician credited with exposing the health crisis.

Lead exposure can affect children in different ways, Hanna-Attisha said.

One of the biggest concerns with the water crisis in regard to teeth is the lack of fluoride from not drinking public water, Hanna-Attisha said. Tap water has added fluoride to prevent dental cavities. When people stopped drinking tap water and transitioned to bottled water, they lost fluoride.

Some bottled water has fluoride, but many does not, Hanna-Attisha added.

In late August, state officials announced children 6 years old and younger during the Flint water crisis were the biggest potential beneficiaries of a historic $600 million settlement with the state of Michigan.

How does lead affect children?

According to the Centers for Disease Control and Prevention, exposure to lead can seriously harm a childs health. The adverse effects can include damage to the brain and nervous system, slowed growth and development, learning and behavior problems, and hearing and speech problems.

The health effects can include lower IQ, decreased ability to pay attention, and underperformance in school.

Hanna-Attisha said based on the science of lead, there is no safe level of lead that children can be exposed to.

Its probably the oldest and most well-studied of poisons, Hanna-Attisha said. Weve known about the evil of lead literally for centuries, weve known that lead was bad. Levels that we thought were OK decades ago when we had a lot of lead in paint and gasoline and plumbing - we now know through amazing science and research that theyre no longer OK.

Hanna-Attisha works with Neurodevelopmental Center of Excellence, located inside the Genesee Health System at 420 W. Fifth Ave., to offer assessments to children and individuals impacted by the Flint water crisis.

The big crux of our work, especially with the neurodevelopmental center is to see how kids are doing now and to get them what they need, now, Hanna-Attisha said.

To receive a free and Medicaid covered neuropsychological assessment, the individual must meet several requirements. Visit here to see the list.

Lead in paint, gasoline and plumbing were all banned, starting with gasoline in 1970, leaded-paint in 1978, and lead in plumbing in 1986. However, at the time lead free was defined as solder and flux with no more than 0.2 percent lead and pipes with no more than 8 percent, according to the U.S. Environmental Protection Agency.

Lead is quickly absorbed into the bloodstream. The half-life (time it takes for the amount to decline by 50 percent) of lead in blood is 30 days; some of the absorbed lead is excreted in urine, sweat, and feces. However, some of the absorbed lead is stored in other body tissues, mostly in bone. A persons body burden of lead is the total amount of lead that has accumulated from exposure over time and is stored in the body, said Perri Zeitz Ruckart, health scientist, for Lead Poisoning Prevention and Surveillance Branch, National Center for Environmental Health and Centers for Disease Control and Prevention.

Hanna-Attisha said when issues do present after being exposed to lead, its hard to prove causation.

Its really hard because theres a long time lag of the time from when youve been exposed to when you have a problem. In addition, the problem that you have - say its a learning disability - it can be caused by lots of other stuff too, right?

Hanna-Attisha pointed out issues that stem from lead exposure are multifactorial. Conditions such as poverty, poor nutrition and poor schools can all contribute to learning disability or issue.

Its so important that we have sequential assessments of people so that we can continue to follow folks over time, said Hanna-Attisha. So we can see the potential consequences.

Lead in families

Dixon is a bright, 5-foot-9, intuitive fifth grader at Eagles Nest Academy. Her teachers describe her as a leader in class.

She was 4 years old when the water was switched.

All her blood levels are perfect, shes fine as far as thats concerned. Her teeth - the dentist said it could possibly be that (exposure to lead) but all her blood work says shes fine, so nobody said shes lead poisoned. So, its like how do you determine that? McDonald asked.

In adults, approximately 94 percent of the total body burden of lead is stored in the bones and teeth compared to approximately 73 percent in the bones and teeth of children, according to Zeitz Ruckart.

Bone lead has a half-life of years to decades. Although lead in blood represents only a portion of the total body burden, a blood lead test is the best readily available way to assess a persons exposure to lead, Zeitz Ruckart said.

There are many different factors that affect blood lead levels such as the source of exposure, length of exposure, and underlying susceptibility (childs age, nutritional status, and genetics)," Zeitz Ruckart added. "Even in the absence of exposure, blood lead levels can rise during periods of bone turnover, which include periods of growth, metabolic disease, pregnancy, lactation, osteoporosis.

The issue of lead is a complex issue and often new studies are published that reveal more issues and findings as to how lead works and its harmful effects on humans, according to Hanna-Attisha.

McDonald said she talks to her daughter frequently about the lead situation because she knows its a lot for a child to understand.

She had dental surgery back in 2015, because of all the corrosion in her mouth, McDonald said. They put a lot of caps and stuff in her mouth and a bar.

Hanna-Attisha noted in regard to teeth about national studies that showed kids who drank bottled water had more cavities and worse teeth, but less lead exposure.

Healthy Kids Dental has been in the area for quite some time and it offers free dental care for those who are on Medicaid. The Flint Registry refers kids to Mott Dental as well, according to Hanna-Attisha.

Takisha Moller was pregnant with her daughter Destinee Wilson in 2014, the year the city switched its water supply.

I tasted metal when I was pregnant, like every time the water was boiled, I tasted metal and I told him (Destinees father), I cant drink this water, it tastes like metal. But I kept drinking it, Moeller said. I drank it all the way until they finally said lead was in the water, but that was after she was born.

After Mollers daughter was born she continued to boil the water, just as the city advised, to give her newborn baths.

I was feeding my baby lead all this time, drinking all this water, giving her baths in the lead water and I know it can soak through your skin and all of that so my first thought was: Is her brain going to be OK? Because she lived in my womb for 10 months - I was overdue. I was just worried about her well being and her development and stuff.

When Destinee was three or four months old, Moller remembers the city dropping bottled water off at her home for the family to drink, cook and clean with.

Sometimes I want to ignore it, Moller said of the issues shes noticed in her daughter. Sometimes I want to look past it, but you have to face it.

At nearly 2 years old, Moller observed her daughter wasnt making any strides toward talking. The toddler can be aggressive and she has a learning disability, the mother added.

Its just going to be a watch and wait game, I guess, Moller said as she sighed.

While Moller was growing her baby, fibroid tumors were also growing inside her uterus. The mother of one is scheduled to have a hysterectomy.

So now, I cant have any more kids because Im having a hysterectomy soon. I was just pregnant in February, Moller said. They gave me a surgery a year after Destinee was born to remove some of the fibroid tumors, they took them out but they grew back.

Moller said doctors told her the tumors are related to her drinking the lead water.

I try not to think about it, Moller said before she took a long pause. Im a very positive person. I have been through a lot in my life, so I have learned to take the bad things and spin them into something positive for myself because I understand that no matter what happens, the past is the past and you create your own future.

Lead prevention

Childhood lead poisoning is entirely preventable, according to both Hanna-Attisha and Zeitz Ruckart.

Theres no magical treatment besides prevention, Hanna-Attisha said. So when we realized theres not a magic pill we can give our patients, our focus became: what can we do to limit the impact of this exposure?

The focus of the Neurodevelopmental Center of Excellence studies how learning and behavior are related to brain development and neural networks through comprehensive neuropsychological assessments.

The center is a resource to help with secondary prevention of lead, said Hanna-Atttisha.

Things that help can help with secondary prevention include good nutrition, educational enrichments and mental health support.

Children can be buffered from a lot of those issues if its implemented in their lives, Hanna-Attisha said.

The Flint Registry, a tool built by the community of Flint to connect people to services and programs to promote health and wellness while navigating a health crisis, can provide support for families in those areas.

A partnering program to help provide good nutrition to the families of Flint is the nutrition prescription program, managed by Michigan State University and Hurley Childrens Hospital Pediatric Public Health Initiative, where $15 for healthy foods are prescribed to young patients by their pediatrician.

Chantel Dawson, research assistant for the nutrition prescription program, collects data from the program.

We aim to help individuals maintain a healthy lifestyle - dietary changes, like longevity, Dawson said. So with the program, we provide a prescription for $15, which can be redeemed at the Farmers' Market or it can also be redeemed at our mobile market, which is Flint Fresh.

Dawson said shes noticed more families have been taking advantage of the prescription since the pandemic.

Ive had individuals tell me that they saved it (the prescription) for Thanksgiving and they cooked a healthy Thanksgiving meal with nothing but vegetables, Dawson said. We had individuals even during the pandemic who werent receiving unemployment or any type of food assistance and they were relying on their appointment with their doctor because if they cant go to the clinic, we also offer services via telehealth.

Dawson said one of the things the program has focused on in the last several months is accessibility. The program has now expanded its delivery services outside of Flint and throughout Genesee County.

We are trying to make sure that we give them accessibility still during the hardest times that were going through, Dawson said.

The CDC supports state and local health departments through cooperative agreements to support childhood lead poisoning prevention activities including strengthening: blood lead testing and reporting, surveillance, linking children to recommended follow-up services, and targeted population-based interventions, according to Zeitz Ruckart.

Our work in recovery is holistic, said Hanna-Attisha. Nobody says that this water crisis was just a lead crisis because it it so much more than that. We have been framing everything as a trauma, this was one trauma and really leaning on the science of trauma and being trauma informed and thats kind of driven our holistic science-based community driven response.

Related news:

Leaders urge citizens impacted by Flint water crisis to get help through the Flint Registry

Flint families ponder what the water crisis settlement really means for them

12 critical moments in the history of the Flint water crisis

Original post:
Flint children exposed to lead suffer from dental problems, learning disabilities, other issues - MLive.com

Read More...

The Importance of Deep Water in Fall Bass Fishing – Wired2Fish

October 25th, 2020 5:54 am

As the calendar gets closer to November and December, it's imperative to keep a close eye out for a fall spawn. The large majority of anglers would tell you that bass only spawn in the spring, but that's simply not true. According to nationally renowned fisheries biologist Steven Bardin, it's much more common than you'd think, especially with Florida-genetic bass. And guess what? Florida-genetic bass are becoming increasingly prevalent throughout the country.

"We all know that the spawn starts in the spring," Bardin said. "Those bass will come to bed when the water temperatures reach around 65 degrees. The largest females spawn first, but they don't drop all of their eggs initially. They only drop 50 percent of their eggs at first. They they'll leave that bed and find another bed about a month later. Then they'll do it a third time.

"When summer rolls around, they start producing eggs for the next year. If we have a fall with a prolonged warm stretch, those eggs will ripen and they'll go ahead and spawn. You'll see this more often in low bass-density fisheries when competition is low. So when a one- or two-week warm snap occurs and combines with low density, you'll see a lot of fall spawning."

For the longevity of the hatched fry, this fall spawn has its pros and cons.

"When a bass spawns early, such as in the late fall, their fry will be bigger when all of the other bass spawn in the spring," Bardin said. "That fry will be nearly 3 inches and now it can outcompete the spring fry and even eat them. On the other hand, however, a big female with great genetics can spawn in the fall and then a cold front comes and kills all of the fry. It's a risky proposition."

Bardin also notes that if the water is below 70 degrees during the fall and it suddenly spikes above the 70-degree mark for a week or two, a fall spawn will often be triggered. This doesn't mean you need to go look in dirt-shallow water like you would in the spring, though. Fall spawning activity tends to occur in-you guessed it-shallow areas with adjacent deep water.

This explanation makes a lot of sense to me. I caught the biggest bass of my life, a 13.14-pounder, on November 2, 2017 in two feet of water. I had no idea about the fall spawn at that point, to be honest. The water was a little dirty and I was mindlessly flipping a creature bait at the same limb for about 10 minutes while I was having a conversation with a buddy. After countless flips, I felt a little "tick" at the end of my line and it was game-on.

Bardin isn't just a biologist source for Wired2fish; he's also a friend of mine. So I called him after I caught and released the 13-pounder and he asked me what the weather had been like. I told him it was too warm that week to deer hunt, so I went fishing instead. He simply replied with, "Yep, she was on bed. You caught a fall spawner."

I went back and looked at the video of the catch and all of the pictures and sure enough, her tail was bloody and she looked like she was slap-full of eggs. She was also just a few yards from 15 feet of water. Although I didn't mean to catch her, it was a real eye opener to me. That fish catch changed my approach to fall fishing.

See the rest here:
The Importance of Deep Water in Fall Bass Fishing - Wired2Fish

Read More...

Genomic Biomarker Market Growth, Demands, CAGR, Sales Volume, Opportunities, Types, Applications and Forecast up to 2023 – The Think Curiouser

October 25th, 2020 5:54 am

Market Overview of Genomic Biomarker Market

The Genomic Biomarker market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Genomic Biomarker market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.researchmoz.com/enquiry.php?type=S&repid=2812407&source=atm

Market segmentation

Genomic Biomarker market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

segment by Type, the product can be split intoOncologyCardiologyNeurologyNephrology

Market segment by Application, split intoHospitalsDiagnostic and research laboratories

Based on regional and country-level analysis, the Genomic Biomarker market has been segmented as follows:North AmericaUnited StatesCanadaEuropeGermanyFranceU.K.ItalyRussiaNordicRest of EuropeAsia-PacificChinaJapanSouth KoreaSoutheast AsiaIndiaAustraliaRest of Asia-PacificLatin AmericaMexicoBrazilMiddle East & AfricaTurkeySaudi ArabiaUAERest of Middle East & Africa

Regional analysis is another highly comprehensive part of the research and analysis study of the global Genomic Biomarker market presented in the report. This section sheds light on the sales growth of different regional and country-level Genomic Biomarker markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Genomic Biomarker market.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.researchmoz.com/enquiry.php?type=E&repid=2812407&source=atm

The report offers in-depth assessment of the growth and other aspects of the Genomic Biomarker market in important countries (regions), including:

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, etc.)

Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Genomic Biomarker competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Genomic Biomarker sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Genomic Biomarker sales, revenue and market share for each player covered in this report.

In the competitive analysis section of the report, leading as well as prominent players of the global Genomic Biomarker market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.The key players covered in this studyBio-RadBeckman CoulterMyriad GeneticsThermo Fisher ScientificRocheQIAGENEpigenomicsAlmacPfizerHuman LongevityValiRxPersonalisEagle GenomicsEmpire GenomicsAgilentIllumina

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2812407&licType=S&source=atm

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Genomic Biomarker product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Genomic Biomarker, with price, sales, revenue and global market share of Genomic Biomarker in 2018 and 2019.

Chapter 3, the Genomic Biomarker competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Genomic Biomarker breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.

Chapter 12, Genomic Biomarker market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.

Chapter 13, 14 and 15, to describe Genomic Biomarker sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Contact Us:

ResearchMoz

Tel: +1-518-621-2074

USA-Canada Toll Free: 866-997-4948

Email: [emailprotected]

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfil all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organisations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Continued here:
Genomic Biomarker Market Growth, Demands, CAGR, Sales Volume, Opportunities, Types, Applications and Forecast up to 2023 - The Think Curiouser

Read More...

Does Family History Of Diabetes Mean That I Will Inherit It Too? – NDTV Doctor

October 25th, 2020 5:54 am

A person is at risk of getting diabetes if s/he has family history of it. But the chances of getting diabetes depend on the person's lifestyle and several other risk factors. Read here to know.

Diabetes risks depends on factos like diet, lifestyle and level of physical activity

Diabetes is largely considered to be inherited, if our parents or anyone in our direct family has diabetes, there is a great possibility that you may inherit it.If you keep eating what your parents and grandparents ate, there is a good chance you will inherit their diabetes. The lifestyle you have so unknowingly inherited from your parents is making you ask this question! Let us get a few facts clear first. Research says that genetics account for 20% of lifestyle disorders, the rest is down to your lifestyle and the environment, of which lifestyle dominates at around 70%.

Having said that when we speak of type 2 diabetes, it is a lifestyle disorder (Type 1 diabetes is the result of a genetic defect and really has no natural cure for it). We call it a lifestyle disorder because it occurs as a result of what you eat, what you think, how you sleep, if you are active, what you do, basically a culmination of your day to day activities. This means, if you alter your lifestyle, there is a 70% chance that you will not inherit diabetes. Seems like a fair deal doesn't it? But you should know where you go wrong, and before diving deeper, be rest assured that your diet alone can have an alarming effect on type 2 diabetes.

Also read:Five Effective Ways To Manage Diabetes When Suffering From Kidney Disease

We fall prey to the whole genetics and mass psychology trap. We have been made to believe that we will inherit diabetes and other related disorders like cardiovascular disease and cancer just because our elders had them. Well, you do have a similar genetic structure, but you can definitely improve your knowledge on the subject of nutrition and how food forms the very essence of longevity. To take an example here, the whole claim of consuming more animal-based proteins to reduce weight and manage diabetes better is false. The science and research do not back this up 1. While it may give you short terms results, in the long term it proves to be highly detrimental.

We would often see that parents who do not exercise much have the same effect on their kids (ofcourse there will be exceptions from one generation to the other), and similarly if they enjoy junk food, so does the offspring. It is these habits that are being referred to. Also, it is important to note that there is a group of parents who are very health conscious, but is their knowledge on the subject sufficient to ensure that they kids do not inherit diabetes? Sadly, that is not the case. Today, what the food industry deems as healthy, actually isn't. How are we able to consume more and more packaged foods today? Why is the size of the fruit and vegetable corner at the supermarket reducing in size? Well, they don't want us to stay healthy 2. They have been fooling us for decades and we have ended up implementing it all without verifying the facts. This is called mass psychology and modern-day marketing folks. We humans tend to get swayed easily. An advertisement with an elite athlete showcasing a new protein rich snack is released and it has us all running to buy it.

Also read:Can Weight Loss Help You Control Blood Sugar Levels? Here's The Link Between Weight Loss And Diabetes

Open your minds and think for yourself for once. Do your research and listen to your body. Our bodies are designed to heal and repair themselves. Diabetes is just an abnormality that can be a thing of the past. There is enough evidence published that people who consume a predominantly vegetarian diet 3 and very little to none of animal-based produce, have shown greater improvement and resilience to health issues like diabetes, hypertension, obesity and heart disorders 4. A diet rich in vegetables, fruits, grains, cereals, nuts & seeds has been proven to promote healthier body weight and BMI, greater insulin sensitivity and hormonal balance.

Before concluding, there has to be a mention that the right kind of natural, plant-based vitamins and supplements should be consumed for preventing/reversing diabetes, and on the whole to maintain longevity and stay clear of any other lifestyle disorders 5. We often fail to realize the power our food possesses. When consumed in the concentrated form, it can have miraculous results in the body 6.

And the answer is NO, you will not inherit diabetes provided you do not blindly follow a lifestyle that has been inherited or falsely created by the food industry. Eat scientifically correct food, get enough sleep, keep moving and stay happy!

Following a healthy lifestyle can help in reducing the risk of diabetesPhoto Credit: iStock

Also read:Diabetes Risk Factors: These 5 Factors Can Increase Your Risk Of Diabetes

Sources:

1. C Xiao, A Giacca, A Carpentier, G F Lewis. Differential effects of monounsaturated, polyunsaturated and saturated fat ingestion on glucose-stimulated insulin secretion, sensitivity and clearance in overweight and obese, non-diabetic humans. Diabetologia. 2006 Jun;49(6):1371-9.

2. Zimmerman FJ. Using marketing muscle to sell fat: the rise of obesity in the modern economy. Annu Rev Public Health. 2011; 32:285-306.

3. R. Vegetarian Diets in the Prevention and Management of Diabetes and Its Complications. Diabetes Spectr. 2017;30(2):82-88.

4. Wright N, Wilson L, Smith M, Duncan B, Mchugh P. The BROAD study: A randomised controlled trial using a whole food plant-based diet in the community for obesity, ischaemic heart disease or diabetes. Nutr Diabetes. 2017;7(3):e256.

5. Beaudart C, Buckinx F, Rabenda V, Gillain S, Cavalier E, Slomian J, Petermans J, Reginster JY, Bruyere O. The effects of vitamin D on skeletal muscle strength, muscle mass, and muscle power: a systematic review and meta-analysis of randomized controlled trials. J ClinEndocrinolMetab. 2014 Nov;99(11):4336-45.

6. W Stonehouse, C A Conlon, J Podd, S R Hill, A M Minihane, C Haskell, D Kennedy. DHA supplementation improved both memory and reaction time in healthy young adults: a randomized controlled trial. Am J ClinNutr. 2013 May;97(5):1134-43.

Promoted

(Vaibhav Garg, Clinical & Sports Nutritionist and Founder, Purecise)

Disclaimer: The opinions expressed within this article are the personal opinions of the author. NDTV is not responsible for the accuracy, completeness, suitability, or validity of any information on this article. All information is provided on an as-is basis. The information, facts or opinions appearing in the article do not reflect the views of NDTV and NDTV does not assume any responsibility or liability for the same.

Follow this link:
Does Family History Of Diabetes Mean That I Will Inherit It Too? - NDTV Doctor

Read More...

Rheumatoid Arthritis Stem Cell Therapy Market | North America and Europe Currently Lead in the Market – BioSpace

October 23rd, 2020 2:58 pm

Rheumatoid arthritis is an inflammatory disease of the body's supportive tissues, usually affecting an individual's toes and fingers. Inflammation is triggered by an abnormal response to the body's normally functioning tissues. This results in malformed joints and severe pain. Stem cells are novel cells that are generated in regenerative centers of the body. They can be transformed into any other cell type in the body with the right kind of stimulus.

Stem cell therapy for rheumatoid arthritis works on the principle of such cellular replacement. Stem cells are injected into a patient's body and are transformed on site into anti-inflammatory cells that limit the spread of this disease. Stem cells work better than traditional inflammation suppressing medicines because they are more organic and act in a targeted manner. In light of the development of innovations in allopathic medicine and demand of people for better healthcare facilities, the market for rheumatoid arthritis stem cell therapy is expected to grow at a commendable pace from 2019 to 2029, opines TMRR.

Get Brochure of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=6864

Global Rheumatoid Arthritis Stem Cell Therapy Market: Competitive Landscape

Handful of pharmaceutical manufacturing facilities is seen to be involved in the production of stem cell therapy solutions.

Significant players n the market include.

Some of these manufacturers are established players in the pharmaceutical industry and have branched into the foray of stem cell therapy. Their established base for pharmaceutical therapy makes the distribution and marketing of stem cell therapy easier. Innovations in this market scenario are funded by these players to increase patient compliance with therapy.

Global Rheumatoid Arthritis Stem Cell Therapy Market: Key Trends and Drivers

Buy this Premium Report @ https://www.tmrresearch.com/checkout?rep_id=6864&ltype=S

Global Rheumatoid Arthritis Stem Cell Therapy Market: Regional Analysis

North America and Europe currently lead in the rheumatoid arthritis stem cell therapy market. This might be because of the presence of a robust healthcare infrastructure that is under pressure from people for better facilities. Moreover, most innovatory laboratories are based in these regions and enjoy supple funding from regional governments. Population in these regions too is more aged than in other regions of the world. Hence, market growth for stem cell therapy should be good here.

The Asia Pacific region (APAC) is expected to register the fastest growth in this market in the coming years. A growing healthcare infrastructure that derives protocol from western medicine should support the growth of stem cell therapy. Population here is also expected to age in future decades, and an increasingly stressful lifestyle shall undoubtedly bring an increase in incidence of stressful conditions like rheumatoid arthritis.

Based on treatment type, the global rheumatoid arthritis stem cell therapy market can be segmented into:

Based on application, the global rheumatoid arthritis stem cell therapy market can be segmented into:

Based on distribution channel, the global rheumatoid arthritis stem cell therapy market can be segmented into:

Based on geography, the global rheumatoid arthritis stem cell therapy market can be segmented into:

Get Table of Content of the Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=6864

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in todays supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Contact:

Rohit Bhisey

TMR Research,

3739 Balboa St # 1097,

San Francisco, CA 94121

United States

Tel: +1-415-520-1050

Visit Site: https://www.tmrresearch.com/

Read the rest here:
Rheumatoid Arthritis Stem Cell Therapy Market | North America and Europe Currently Lead in the Market - BioSpace

Read More...

Canine Stem Cell Therapy Market: Know about Impact of Covid-19 by Top Companies like MediVet Biologic, VetStem Biopharma, Stem Cell Vet, Regeneus…

October 23rd, 2020 2:58 pm

The latest report published by Zeal Insider provides an in-depth analysis on the Canine Stem Cell Therapy Market with actual market values for the years 2018 and 2019 along with forecast for a period from 2020 to 2028. Thereby, the report provides historic market figures for the years 2018 and 2019 and offers an insight into the impact of COVID-19 on the Canine Stem Cell Therapy market for the forecast period from 2020 to 2028. The purpose of this study is to provide a detailed overview on the Canine Stem Cell Therapy market in pre-COVID-19 conditions and further provide information of how the market has changed since the onset of the pandemic.

Key players profiled in the report includes:MediVet Biologic, VetStem Biopharma, Stem Cell Vet, Regeneus Ltd, Okyanos, Aratana Therapeutics

Request for a Sample Report of Canine Stem Cell Therapy Market: https://www.zealinsider.com/report/1356/canine-stem-cell-therapy-market#sample

The investigative report provides a detailed analysis of the Canine Stem Cell Therapy market covering several aspects such as market dynamics, growth drivers, restraining factors, opportunities, challenges and recent developments in the market. The study has been collated based on exhaustive secondary research after studying numerous industry publications, government reports, company news and press releases. Further, these findings are backed by detailed primary research after interviewing numerous key opinion leaders, market participants, end-users and various other stakeholders in the Canine Stem Cell Therapy market.

The research report provides a detailed analysis on the Canine Stem Cell Therapy market segmented on the basis of type, application, end-use and geography. Thereby, the report aims to provide granular information on the performance of various product types based on its applications and end-use across key market countries across the world. The idea behind the report is to provide its audience with actionable insights on which market segments are more profitable currently and others which offer growth opportunities during the forecast period from 2020 to 2028.

The report provides a detailed competitive landscape including company profiles for leading market participants in the Canine Stem Cell Therapy market. Some of the details included in the company profile are product/service offering, financial information, business strategies and recent developments, among others. Furthermore, the report provides an in-depth company mapping based on their market share, revenues, growth and geographic presence. Thereby, the report includes a detailed analysis of various companies operating across the globe. Leading companies covered in the report include MediVet Biologic, VetStem Biopharma, Stem Cell Vet, Regeneus Ltd, Okyanos, Aratana Therapeutics, among others.

Place Inquiry for Buying or Customization of Report: https://www.zealinsider.com/report/1356/canine-stem-cell-therapy-market#inquiry

Canine Stem Cell Therapy Market Segmentation:

The report offers in-depth analysis of the Canine Stem Cell Therapy market based on various segments such as type, application and end-use industry. The Canine Stem Cell Therapy market is segmented as follows:

Canine Stem Cell Therapy Market, by Type:Allogeneic Stem Cells, Autologous Stem Cells

Canine Stem Cell Therapy Market, by Application:Veterinary Hospitals, Veterinary Clinics, Veterinary Research Institutes

Companies included in the Canine Stem Cell Therapy Market report:MediVet Biologic, VetStem Biopharma, Stem Cell Vet, Regeneus Ltd, Okyanos, Aratana Therapeutics

Geographic Coverage

The report on the Canine Stem Cell Therapy market provides a detailed country-level cross-sectional analysis across various regions around the globe. The report contains detailed market size and forecast for the following countries and regions:

North America Canine Stem Cell Therapy Market Revenue and Forecast

Europe Canine Stem Cell Therapy Market Revenue and Forecast

Asia Pacific Canine Stem Cell Therapy Market Revenue and Forecast

Latin America Canine Stem Cell Therapy Market Revenue and Forecast

Middle East and Africa Canine Stem Cell Therapy Market Revenue and Forecast

Access Full Report, here: https://www.zealinsider.com/report/1356/canine-stem-cell-therapy-market

This report provides an investigative analysis of the Canine Stem Cell Therapy market encapsulated in detailed sections such as

See more here:
Canine Stem Cell Therapy Market: Know about Impact of Covid-19 by Top Companies like MediVet Biologic, VetStem Biopharma, Stem Cell Vet, Regeneus...

Read More...

Stem Cell Therapy Market 2020-2026 | XX% CAGR Projection Over the Next Five Years, Predicts Market Research Future with Market Size & Growth Key…

October 23rd, 2020 2:57 pm

Stem Cell Therapy Market report would come handy to understand the competitors in the market and give an insight into sales, volumes, revenues in the Stem Cell Therapy Industry & will also assists in making strategic decisions. The report also helps to decide corporate product & marketing strategies. It reduces the risks involved in making decisions as well as strategies for companies and individuals interested in the Stem Cell Therapy industry. Both established and new players in Stem Cell Therapy industries can use the report to understand the Stem Cell Therapy market.

In Global Market, the Following Companies Are Covered:

Get a Sample Copy of the Report @ https://www.360marketupdates.com/enquiry/request-sample/14849805

Analysis of the Market:

Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.

In the last several years, global stem cell therapy market developed fast at a average growth rate of 46.81%.

Market Analysis and Insights: Global Stem Cell Therapy Market

In 2019, the global Stem Cell Therapy market size was USD 403.6 million and it is expected to reach USD 1439.9 million by the end of 2026, with a CAGR of 19.7% during 2021-2026.

Global Stem Cell Therapy Scope and Market Size

Stem Cell Therapy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Stem Cell Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Stem Cell Therapy market is segmented into Autologous, Allogeneic, etc.

Segment by Application, the Stem Cell Therapy market is segmented into Musculoskeletal Disorder, Wounds & Injuries, Cornea, Cardiovascular Diseases, Others, etc.

Regional and Country-level Analysis

The Stem Cell Therapy market is analysed and market size information is provided by regions (countries).

The key regions covered in the Stem Cell Therapy market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.

Competitive Landscape and Stem Cell Therapy Market Share Analysis

Stem Cell Therapy market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Stem Cell Therapy business, the date to enter into the Stem Cell Therapy market, Stem Cell Therapy product introduction, recent developments, etc.

The major vendors include Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, JCR Pharmaceutical, Pharmicell, Medi-post, Anterogen, Molmed, Takeda (TiGenix), etc.

This report focuses on the global Stem Cell Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Stem Cell Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

Stem Cell Therapy Market Breakdown by Types:

Stem Cell Therapy Market Breakdown by Application:

Critical highlights covered in the Global Stem Cell Therapy market include:

The information available in the Stem Cell Therapy Market report is segmented for proper understanding. The Table of contents contains Market outline, Market characteristics, Market segmentation analysis, Market sizing, customer landscape & Regional landscape. For further improving the understand ability various exhibits (Tabular Data & Pie Charts) has also been used in the Stem Cell Therapy Market report.

Get a Sample Copy of the Report @ https://www.360marketupdates.com/enquiry/request-sample/14849805

Reasons for Buy Stem Cell Therapy Market Report:

In the end, Stem Cell Therapy Industry report provides the main region, market conditions with the product price,profit, capacity, production, supply, demand and market growth rateand forecast etc. This report also Present newproject SWOT analysis,investment feasibility analysis, andinvestment return analysis.

Contact Us:

Name: Mr. Ajay More

Email: [emailprotected]

Organization: 360 Market Updates

Phone: +14242530807 / + 44 20 3239 8187

Valencene Market Size Research Report 2020-2026,Comprehensive Study, Development Status, Opportunities, Future Plans, Competitive Landscape and Growth

Enhanced Fire Protection Systems Market Size 2020,Growth Factors, Business Opportunity,Segmentation and Forecast to 2026 Research Reportby implies of360 Market Updates

Antifungal Agents Market Size, Defination, Industry Trends, News andlargeGrowth With Regional Trends By Forecast 2026 Research Reportwith the aid of360 market updates

Rainboots Market Size 2020-2026 Industry Trends, Size, Segments, Competitors Classification, Growth, Up and Down Stream Industry Analysis and Forecast

Ku-Band LNB Market Size & Growth, Sales Revenue, Key Players Analysis, Development Status, Opportunity Assessment and Industry Expansion Strategies 2025 Research Reportwith the aid of360 market updates

ITO Glass Market Size 2020-2026 Research Report by Key Companies, Future Trend, Pipeline Projects, Product, Application, Growth and Regional Forecasts

Perfluoropolyethers Market Size 2020,Business Opportunity, SWOT Analysis, Applications, Trends and Forecast to 2026 Research Reportby360 Market Updates

Visit link:
Stem Cell Therapy Market 2020-2026 | XX% CAGR Projection Over the Next Five Years, Predicts Market Research Future with Market Size & Growth Key...

Read More...

Adipose Tissue-derived Stem Cell Therapy Market: Worldwide Industry to Boost in the Period of 2020-2025 – Express Journal

October 23rd, 2020 2:57 pm

The study on Adipose Tissue-derived Stem Cell Therapy market provides thorough insights pertaining to major growth drivers, challenges, and opportunities that will influence the industry expansion in the forthcoming years.

According to the research document, the industry is expected to register XX% CAGR over the forecast period (2020-2025), subsequently accruing significant gains by the end of analysis timeframe.

The market is in a disarray due to the lockdowns imposed for limiting the spread of COVID-19 outbreak. In addition to the sudden slump of revenue, some businesses are expected to tackle a plethora of challenges post the pandemic.

Request Sample Copy of this Report @ https://www.express-journal.com/request-sample/224665

Most of the businesses across various sectors have renewed their budgets to focus on profit gains in upcoming years. Our comprehensive analysis of the business sphere can help stakeholders in making sound decisions to compensate for market uncertainties and support them in building strong contingency plans.

Further, the report provides a granular assessment of the several industry segmentations to convey a deeper understanding of the areas with strong profit potential.

Key inclusions of the Adipose Tissue-derived Stem Cell Therapy market report:

Adipose Tissue-derived Stem Cell Therapy Market segments covered in the report:

Regional segmentation:

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Product types: Autologous Stem Cells and Allogeneic Stem Cells

Applications spectrum: Therapeutic Application and Research Application

Competitive outlook:

Our Market Research Solution Provides You Answer to Below Mentioned Question:

Which are the key factors driving the growth of the industry?

What are the emerging market trends and opportunities for this sector?

What is the future growth trend of this industry?

What is the size of the global and regional sector in terms of volume, size, and revenue?

Which is the most promising region in the global market?

What is the forecasted revenue and volume growth rates of the industry in the coming years?

Which region holds the highest share and what are the market shares of other key regions?

How will each segment and region grow over the years until 2025?

Table of Contents:

Report Overview: It includes major players of the global Adipose Tissue-derived Stem Cell Therapy market covered in the research study, research scope, and Market segments by type, market segments by application, years considered for the research study, and objectives of the report.

Market Share by Manufacturers: Here, the report provides details about revenue by manufacturers, production and capacity by manufacturers, price by manufacturers, expansion plans, mergers and acquisitions, and products, market entry dates, distribution, and market areas of key manufacturers.

Production by Region: Here, the production value growth rate, production growth rate, import and export, and key players of each regional market are provided.

Consumption by Region: This section provides information on the consumption in each regional market studied in the report. The consumption is discussed on the basis of country, application, and product type.

Market Size by Type: This section concentrates on product type segments where production value market share, price, and production market share by product type are discussed.

Market Size by Application: Besides an overview of the global Adipose Tissue-derived Stem Cell Therapy market by application, it gives a study on the consumption in the global Adipose Tissue-derived Stem Cell Therapy market by application

Company Profiles: Almost all leading players of the global Adipose Tissue-derived Stem Cell Therapy market are profiled in this section. The analysts have provided information about their recent developments in the global Adipose Tissue-derived Stem Cell Therapy market, products, revenue, production, business, and company.

Key Findings: This section gives a quick look at important findings of the research study.

Request Customization on This Report @ https://www.express-journal.com/request-for-customization/224665

Continue reading here:
Adipose Tissue-derived Stem Cell Therapy Market: Worldwide Industry to Boost in the Period of 2020-2025 - Express Journal

Read More...

Stem Cell Therapy Market Comprehensive Study COVID19 Impact Analysis 2020-2025 – The Think Curiouser

October 23rd, 2020 2:57 pm

The global Stem Cell Therapy Market research report is a well synchronized synopsis highlighting some of the most significant, real time research analysis that enable quick and efficient business discretion. The report is a quick reference point to make comply with reader understanding of the volatile market situations that collectively steer enormous growth opportunities in the global Stem Cell Therapy Market. The report offers a resourceful outline highlighting various facets that encourage remunerative business decisions in this market. The report draws references of growth-oriented business strategies, concomitant competition, business decisions as well as includes references of dynamic segmentation that collectively ensure steady growth in the global market.

The report categorically sheds ample light on multiply market components such as major trends, persistent challenges as well as barriers and threats that significantly restrict growth in the global Stem Cell Therapy Market. Additionally, to meet with manufacturer needs of opportunity hunting, the report specifically outlines crucial references about major opportunities that steer steady growth and sustainable revenue streams in the global Stem Cell Therapy Market.

Download Sample PDF Brochure with Covid-19 Updates @ https://www.adroitmarketresearch.com/contacts/request-sample/691?utm_source=re

This Stem Cell Therapy Market report also strives to provide an essential understanding of the market development from a past and present perspective for accurate forecasting forecasts. In addition, important details of key market players are also included in the report, replicating the growth-oriented business discretion.

COVID-19 Specific Analysis

This up-to-date research report compilation also entices readers to get equipped with ongoing market developments inclusive of unprecedented developments such as COVID-19 outbreak that has crippled businesses and industrial developments in a myriad ways. The report is structured to highlight effective cues for growth oriented business decisions, allowing manufacturers and stakeholders in the Stem Cell Therapy Market to come up with growth friendly strategies and tactics.

Browse full research report @ https://www.adroitmarketresearch.com/industry-reports/stem-cell-therapy-market?utm_source=re

Understanding regional growth prognosis: global Stem Cell Therapy Market

The next section of the report on the global Stem Cell Therapy Market contains vivid details on regional developments, including details on country-specific events collectively impacting optimistic growth. In addition, important details of key market players are also included in the report, replicating the growth-oriented business discretion. This report also strives to provide an essential understanding of the market development from a past and present perspective for accurate forecasting forecasts.

Stem Cell Therapy Market Segmentation

Type Analysis of Stem Cell Therapy Market:

Based on cell source, the market has been segmented into,

Adipose Tissue-Derived Mesenchymal SCsBone Marrow-Derived Mesenchymal SCsEmbryonic SCsOther Sources

Applications Analysis of Stem Cell Therapy Market:

Based on therapeutic application, the market has been segmented into,

Musculoskeletal DisordersWounds & InjuriesCardiovascular DiseasesGastrointestinal DiseasesImmune System DiseasesOther Applications

Guide to 5 Guidance for Investing in Reports

1. A thorough end-to-end review and analysis of Stem Cell Therapy Market events and their meaning2. Thorough compilation of a wide range of market segments3. Complete demonstration of industry best practices, careful business decisions, and manufacturer activities driving revenue sustainability in the global Stem Cell Therapy Market4. A complete assessment of the competitive spectrum, including relevant details for key and emerging players5. Accurate review of key dynamics and dominant changes influencing the growth of global Stem Cell Therapy Market.

Make An Enquiry About This Report @ https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/691?utm_source=re

About Us :

Contact Us :

Ryan JohnsonAccount Manager Global3131 McKinney Ave Ste 600, Dallas,TX75204, U.S.A.Phone No.: USA: +1 972-362 -8199/ +91 9665341414

Excerpt from:
Stem Cell Therapy Market Comprehensive Study COVID19 Impact Analysis 2020-2025 - The Think Curiouser

Read More...

Be Biopharma debuts with $52M to advance engineered B-cell therapies – FierceBiotech

October 23rd, 2020 2:57 pm

You may have heard of T cells, but Aleks Radovic-Moreno, Ph.D., Be Biopharmas co-founder, president and director, is betting on B cells as the future of cell therapies.

Our mission is to develop what we see as a new class of cell medicines that have a broad new pharmacology, he said of B cells potential. We think it's a big new white space that's enabled by the rich biology of these cells.

The Cambridge, Massachusetts-based company is capitalizingearly on research by scientists at the University of Washington School of Medicine. With a $52 million series A round in the bank, it'smaking a beeline for the clinic.

Digitize remote site monitoring with Box

Box will discuss how your life sciences organization can continue to propel therapies & devices through the value chain with faster and even more secure site monitoring and auditing.

Why the enthusiasm around B cells? The wayRadovic-Moreno sees it, they'rethe cellular gadget, if you will, that's really good at making large amounts of protein, and they also traffic to where you want them to go."

When we think about it from a drug development standpoint, now you have a system that can make a protein that you want in high quantities in places where you want it to be made, he added.

B cells may also be useful for targeting specific tissues and modulating microenvironments, or [talking] to the cells that are nearby, he said.

One of the biggest challenges to bringing Be Bio to fruition was making the products themselves. Theyre harder to engineer than other cell types thanksto their intrinsic biology, Radovic-Moreno said. Theyre also hard to make correctly and in large quantities, challenges the company only recently overcame.

Those two are the final two bottlenecks that were preventing B cells from being a viable stem cell therapy modality, he said.

RELATED: Q32 debuts with $46M to 'rebalance' innate and adaptive immunity

The applications of B cells include everything from autoimmune diseases to cancer and monogenic disorders, which are caused by variation in a single gene. B-cell therapy could eliminate the need for patients with monogenic disorders who are missing proteins to get biweekly four-hour infusions.

And that's not all. It couldalso eliminate the need for bone marrow transplants in these patients, as well asthe need for a pre-therapy round of chemotherapy, otherwise known as conditioning. For cancer patients who need conditioningahead of a stem cell treatment, the regimencan be deadly up to 10% of the time.

That's extraordinary if you think about a therapy killing patients 10% of the time, Radovic-Moreno said.

Beyond pushing Be'spipeline toward the clinic, the new fundingfrom Atlas Venture, RA Capital Management, Alta Partners, Longwood Fund and other investorswill bankroll potential partnerships and build out the company's team.

The most important thing is to build a great company, hire the best people. We want to be the best B-cell engineers in the world and in history, Radovic-Moreno said. We want to fully capitalize on the timing of this, given that it's a very kind of unusual place to be in this time and age of biotech, where you're sitting right in front of this massive blue wave, big blue ocean of possibilities so big.

Continued here:
Be Biopharma debuts with $52M to advance engineered B-cell therapies - FierceBiotech

Read More...

Stem Cell Therapy Market Research Report Forecast to 2029 (Includes Business Impact of COVID-19) – Eurowire

October 23rd, 2020 2:57 pm

Trusted Business Insights answers what are the scenarios for growth and recovery and whether there will be any lasting structural impact from the unfolding crisis for the Stem Cell Therapy market.

Trusted Business Insights presents an updated and Latest Study on Stem Cell Therapy Market. The report contains market predictions related to market size, revenue, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends and developments of the market.The report further elaborates on the micro and macroeconomic aspects including the socio-political landscape that is anticipated to shape the demand of the Stem Cell Therapy market during the forecast period.It also examines the role of the leading market players involved in the industry including their corporate overview, financial summary, and SWOT analysis.

Get Sample Copy of this Report @ Stem Cell Therapy Market Research Report Forecast to 2029 (Includes Business Impact of COVID-19)

Abstract, Snapshot, Market Analysis & Market Definition: Stem Cell Therapy MarketIndustry / Sector Trends

Stem Cell Therapy Market size was valued at USD 7.8 billion in 2018 and is expected to witness 10.2% CAGR from 2021 to 2026.

U.S. Stem Cell Therapy Market Size, By Type, 2018 & 2025 (USD Million)

Rising prevalence of chronic diseases will positively impact the stem cell therapy market growth. Cardiovascular diseases, neurological disorders and other chronic conditions have resulted in high mortality over past few years. Conventional therapeutic methods and treatments are currently replaced due to lack of efficiency and efficacy. Recently developed stem cell therapies are capable of replacing defective cells to treat diseases that has reduced morbidity drastically. Therefore, people have now started relying on stem cell therapy that has long term positive effects.

Advancements in stem cell therapy in developed regions such as North America and Europe have boosted the industry growth. Since past few years, there have been several researches carried out for stem cell therapy. Currently developed stem cell therapies have shown positive outcomes in treatment of leukemia. Similarly, due to advancements in regenerative medicine, several other chronic conditions such as muscular dystrophy and cardiovascular diseases also have been cured. Aforementioned factors have surged the industry growth. However, high cost of allogenic stem cell therapy may hamper the industry growth to some extent.

Market Segmentation, Outlook & Regional Insights: Stem Cell Therapy Market

Stem Cell Therapy Market, By Type

Allogenic stem cell therapy segment held around 39% revenue share in 2018 and it is anticipated to grow substantially during the analysis timeframe. Allogenic stem cell is available as off the shelf therapy and it is easily scalable that helps in providing treatment without delay. Moreover, the procedure includes culturing donor-derived immunocompetent cells that are highly effective in treatment of several diseases. Stem cells obtained in allogenic therapy are free of contaminating tumor cells. This reduces risk for disease recurrence that will surge its demand thereby, stimulating segment growth.

Autologous stem cell therapy segment is estimated to witness 10.1% growth over the forthcoming years. People usually prefer autologous stem cell therapy as it has minimum risk of immunological rejection. However, on introduction of allogenic stem cell therapy, demand for autologous stem cell therapy has declined as it is difficult to scale up. However, there are concerns regarding risk of cross contamination during large scale manufacturing of autologous stem cell lines that will impede segmental growth to some extent.

Stem Cell Therapy Market, By Application

The neurology segment was valued at around USD 1.6 billion in 2018 and it is estimated that it will witness significant growth over the forthcoming years. Stem cells are used to replenish the disrupted neurological cells that help in quick patient recovery. Pluripotent stem cells provide a replacement for cells and tissues to treat Alzheimers, Parkinsons disease, cerebral palsy, amyotrophic lateral sclerosis, and other neurodegenerative diseases. Thus, the pivotal role of stem cells in treating the life-threatening neurological condition will escalate segment growth.

The cardiovascular segment will witness 10% growth over the analysis timeframe. Considerable segmental growth can be attributed to development in stem cell therapies that have enhanced recovery pace in patients suffering from cardiovascular diseases. Recently developed allogeneic stem cell therapies are efficient and easily available that have reduced the mortality rates in cardiovascular patients. Above mentioned factors will propel cardiovascular segment growth in near future.

Stem Cell Therapy Market, By End-users

The hospital segment held over 56% revenue share in 2018 and it is anticipated to grow significantly in near future. The rising preference for stem cell therapies offered by hospitals proves beneficial for business growth. Hospitals have affiliations with research laboratories and academic institutes that carry out research activities for developing stem cell therapies. On the introduction and approval of any novel stem therapy, hospitals implement it immediately. Associations with research and academic institutes further help hospitals to upgrade its stem cell treatment offerings that positively impact the segmental growth.

The clinics segment is expected to grow at around 10% during the forecast timeframe. Clinics specializing in providing stem cell therapies are well-equipped with advanced medical devices and superior quality reagents required for imparting stem cell therapies. However, as clinics offer specialized stem cell therapies, their treatment cost is much higher as compared to hospitals that may reduce its preference.

Stem Cell Therapy Market, By Region

North America stem cell therapy market held around 41.5% revenue share in 2018 and it is estimated to grow substantially in near future. Increasing the adoption of novel stem cell therapies will prove beneficial for regional market growth. Moreover, favorable government initiatives have a positive impact on regional market growth. For instance, the government of Canada has initiated Strategic Innovation Fund Program that invests in research activities carried out for stem cell therapies enabling development in stem cell therapy. Above mentioned factors are expected to drive the North America market growth.

Asia Pacific stem cell therapy market is anticipated to witness 10.8% growth in the near future owing to increasing awareness amongst people pertaining to the benefits of advanced stem cell therapies. Additionally, favorable initiatives undertaken by several organizations will promote industry players to come up with innovative solutions. For instance, according to Pharma Focus Asia, members of the Asia-Pacific Economic Cooperation collaborated with Life Sciences Innovation Forum to involve professionals having expertise in stem cell therapies from academia and research centers to promote developments in stem cell research. Thus, growing initiatives by organizations ensuring the availability of new stem cell therapies will foster regional market growth.

Latin America Stem Cell Therapy Market Size, By Country, 2025 (USD Million)

Key Players, Recent Developments & Sector Viewpoints: Stem Cell Therapy Market

Key industry players in the stem cell therapy market include Astellas Pharma Inc, Cellectis, Celyad, Novadip Biosciences, Gamida Cell, Capricor Therapeutics, Cellular Dynamics, CESCA Therapeutics, DiscGenics, OxStem, Mesoblast Ltd, ReNeuron Group, and Takeda Pharmaceuticals. Chief industry players implement several initiatives such as mergers and acquisitions to sustain market competition. Also, receiving approvals for stem cell therapy products from regulatory authorities fosters the companys growth. For instance, in March 2018, the European Commission approved Takedas Alofisel that is off-the-shelf stem cell therapy. Product approval will help the company to gain a competitive advantage and capture market share.

Stem Cell Therapy Industry Viewpoint

The stem cells industry can be traced back to the 1950s. In 1959 first animals were made by in-vitro fertilization by preserving the stem cells. Till 2000, research was being carried out on stem cells to study its therapeutic effect. In 2000, fund allocations were made to research on cells derived from aborted human fetuses. In the same year, scientists derived human embryonic stem cells from the inner cell mass of blastocytes. Later, in 2010, clinical trials for human embryonic stem cell-based therapy were initiated. As technology progressed, stem cell therapy for treating cancer was developed. However, due to ethical issues, the use of stem cells for curing diseases witnessed slow growth for a few years. But as the regulatory scenario changed, people started preferring stem cell therapies due to its better efficacy. Stem cell therapy is in the developing stage and has numerous growth opportunities in developing economies with a high prevalence of chronic diseases.

Key Industry Development

In September 2020, Takeda Pharmaceutical Company Limited announced the expansion of its cell therapy manufacturing capabilities with the opening of a new 24,000 square-foot R&D cell therapy manufacturing facility at its R&D headquarters in Boston, Massachusetts. The facility provides end-to-end research and development capabilities and will accelerate Takedas efforts to develop next-generation cell therapies, initially focused on oncology with the potential to expand into other therapeutic areas.

The R&D cell therapy manufacturing facility will produce cell therapies for clinical evaluation from discovery through pivotal Phase 2b trials. The current Good Manufacturing Practices (cGMP) facility is designed to meet all U.S., E.U., and Japanese regulatory requirements for cell therapy manufacturing to support Takeda clinical trials around the world.

The proximity and structure of Takedas cell therapy teams allow them to quickly apply what they learn across a diverse portfolio of next-generation cell therapies including CAR NKs, armored CAR-Ts, and gamma delta T cells. Insights gained in manufacturing and clinical development can be quickly shared across global research, manufacturing, and quality teams, a critical ability in their effort to deliver potentially transformative treatments to patients as fast as possible.

Takeda and MD Anderson are developing a potential best-in-class allogeneic cell therapy product (TAK-007), a Phase 1/2 CD19-targeted chimeric antigen receptor-directed natural killer (CAR-NK) cell therapy with the potential for off-the-shelf use being studied in patients with relapsed or refractory non-Hodgkins lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Two additional Phase 1 studies of Takeda cell therapy programs were also recently initiated: 19(T2)28z1xx CAR T cells (TAK-940), a next-generation CAR-T signaling domain developed in partnership with Memorial Sloan Kettering Cancer Center (MSK) to treat relapsed/refractory B-cell cancers, and a cytokine and chemokine armored CAR-T (TAK-102) developed in partnership with Noile-Immune Biotech to treat GPC3-expressing previously treated solid tumors.

Takedas Cell Therapy Translational Engine (CTTE) connects clinical translational science, product design, development, and manufacturing through each phase of research, development, and commercialization. It provides bioengineering, chemistry, manufacturing, and control (CMC), data management, analytical, and clinical and translational capabilities in a single footprint to overcome many of the manufacturing challenges experienced in cell therapy development.

Key Insights Covered: Exhaustive Stem Cell Therapy Market1. Market size (sales, revenue and growth rate) of Stem Cell Therapy industry.2. Global major manufacturers operating situation (sales, revenue, growth rate and gross margin) of Stem Cell Therapy industry.3. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Stem Cell Therapy industry.4. Market size (sales, revenue) forecast by regions and countries from 2019 to 2025 of Stem Cell Therapy industry.

Research Methodology: Stem Cell Therapy Market

Looking for more? Check out our repository for all available reports on Stem Cell Therapy in related sectors.

Quick Read Table of Contents of this Report @ Stem Cell Therapy Market Research Report Forecast to 2029 (Includes Business Impact of COVID-19)

Trusted Business InsightsShelly ArnoldMedia & Marketing ExecutiveEmail Me For Any ClarificationsConnect on LinkedInClick to follow Trusted Business Insights LinkedIn for Market Data and Updates.US: +1 646 568 9797UK: +44 330 808 0580

See original here:
Stem Cell Therapy Market Research Report Forecast to 2029 (Includes Business Impact of COVID-19) - Eurowire

Read More...

Platelet Rich Plasma & Stem Cell Alopecia Treatment Market 2020: Reporting and Evaluation of Recent Industry Developments – Eurowire

October 23rd, 2020 2:57 pm

The report provides study at global and regional level to provide comprehensive value market analysis for the years (2017 & 2018 Historic Years, 2019 Base Year and 2020-2027 Forecast Period). The Platelet Rich Plasma & Stem Cell Alopecia Treatment Market research report is a wide-ranging study of current trends, market growth drivers, and restraints. Each market segment is broadly analyzed at a powdered level by region (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America) to provide thorough information on the global and regional level.

Some of the key players in this market include

Download Sample PDF Brochure of this research study at https://www.theinsightpartners.com/sample/TIPRE00004413/

The global platelet rich plasma & stem cell alopecia treatment market is segmented on the basis of treatment and end user. Based on treatment, the market is segmented as, stem cell therapy and platelet rich plasma therapies. The platelet rich plasma & stem cell alopecia treatment market is categorized based on end user such as, dermatology clinics, hospitals and other end users.

The segmentation in this research study has been finalized post in-depth secondary research and extensive primary research. In addition, the market is also segmented on the basis of technology offered by the leading participants in the industry in order to understand widely used market specific terminologies. Thus, we have incorporated the segments of the research and have finalized the market segmentation.

The Insight Partners Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Research Report Scenario includes:

Order a copy of this research study at https://www.theinsightpartners.com/buy/TIPRE00004413/

The report also covers a detailed chapter of the analysis on COVID-19 impact on this market at global and regional level in our final reports.

This research provides detailed information regarding the major factors influencing the growth of the Platelet Rich Plasma & Stem Cell Alopecia Treatment Market in Global and Regional Level (drivers, restraints, opportunities, and challenges), forecast of the market size, in terms of value, market share by region and segment; regional market positions; segment and country opportunities for growth; New product developments, strengths and weaknesses, brand portfolio; Marketing and distribution strategies; challenges and threats from current competition and prospects; Key company profiles, SWOT, product portfolio and growth strategies.

ABOUT US:

The Insight Partners is a one stop industry research provider of actionable solutions. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are specialist in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Our research model is very simple. We believe in client servicing and delivering best quality to our customers. Through our research content, we are making sure that our customers get value of their money along with better quality data and analysis.

Our research content is majorly focused towards market trends in terms of market sizing, competitive landscaping, company analysis, regional or country analysis etc. We provide detailed break-up of segmentation in terms of geography, technology, product and services etc.; which helps our clients to get a deeper analysis on various research topics.

Contact US:

If you have any queries about this report or would like further information, please contact us:

North America: +1 646 491 9876

Asia-Pacific: +91 20 6727 8686

Email: [emailprotected]

Read the original here:
Platelet Rich Plasma & Stem Cell Alopecia Treatment Market 2020: Reporting and Evaluation of Recent Industry Developments - Eurowire

Read More...

Stem Cell Therapy Market Revenue, Key Players, Supply-Demand, Investment Feasibility and Forecast 2026 – The Think Curiouser

October 23rd, 2020 2:57 pm

Global Stem Cell Therapy Market Research Assessment and Forecast 2020 2028 offers an assessment of the global Stem Cell Therapy market and a forecast of market demand by type and segment of end users. This study offers a comprehensive industry assessment as it includes statistically validated and validated industry market data, facts, critical findings, and historical data. It also contains predictions made using an appropriate set of methodologies to obtain accurate values. Market analysis offers information according to the categories identified through market segmentation, which includes product type, geography and applications.

Get a Sample PDF copy of the Stem Cell Therapy Market report @ https://www.adroitmarketresearch.com/contacts/request-sample/691?utm_source=bh

Provides a worldwide analysis of Stem Cell Therapy market growth for both regional and global markets, including an understanding of business strategy, development trends, opportunities and development status of important regions.

The study provides quantitative information on key industry trends, market size (value and volume) and development of each end-user segment of Stem Cell Therapy, import / export of Stem Cell Therapy by region, production volume and main country. Historical and future consumption trends, as well as market innovations, as well as the challenges faced by major Stem Cell Therapy manufacturers as well as end users, are suggested.

Browse the complete report Along with TOC @ https://www.adroitmarketresearch.com/industry-reports/stem-cell-therapy-market?utm_source=bh

Each market participant included in the Stem Cell Therapy market study is ranked according to its manufacturing coverage, market share, existing and new launches, ongoing R&D projects and business strategies. In addition, market research for Stem Cell Therapy provides an assessment of strengths, weaknesses, opportunities and threats (SWOT). The report assesses and explores the prospects for the global platelet market, including sales, production and use, as well as historical data and projections.

Stem Cell Therapy Market Segmentation

Type Analysis of Stem Cell Therapy Market:

Based on cell source, the market has been segmented into,

Adipose Tissue-Derived Mesenchymal SCsBone Marrow-Derived Mesenchymal SCsEmbryonic SCsOther Sources

Applications Analysis of Stem Cell Therapy Market:

Based on therapeutic application, the market has been segmented into,

Musculoskeletal DisordersWounds & InjuriesCardiovascular DiseasesGastrointestinal DiseasesImmune System DiseasesOther Applications

Market research monitors the global situation and explains how the industry will create promising profit margins for manufacturers in the post-COVID-19 crisis. The market research aims to offer further information on the economic downturn, the latest scenario and the impact of COVID-19 on the industry as a whole.

Scope of the global Stem Cell Therapy Market Report:

This research covers detailed manufacturer data such as shipment, price, gross margin, interview record, revenue, business distribution, etc. This data helps the user to get to know the competition better. The report also includes all regions and countries of the world, showing the complex status of regional growth such as market size, volume and value, and price data.

Likewise, the study also covers segment data, including segment type, market segment, channel segment, and so on, which contains different market segment sizes, both in value and volume. In addition, it covers consumer data from different industries, which is very important for service providers.

Analyzing the Investment Potential of the Global Stem Cell Therapy Market Report

The report hovers across the past and current dynamics to deduce significant developments in the aforementioned market, thus effectively encouraging agile business outcome The report also is a ready-to-refer documentation that entails substantial information featuring the developments across segments and their role in growth optimization Systematic R&D activities and concomitant resource planning are thoroughly touched upon in this report featuring the development graph in global Stem Cell Therapy market. The report also ensures investor participation towards directing manufacturer and vendor activities in a bid to achieve significant competitive edge. Market based developments are also accurately sectioned in both value-based volume-based calculations to thoroughly encourage reader understanding and subsequent growth potential in global Stem Cell Therapy market.

Make an Enquiry for purchasing this Report @ https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/691?utm_source=bh

About Us :

Contact Us :

Ryan JohnsonAccount Manager Global3131 McKinney Ave Ste 600, Dallas,TX75204, U.S.A.Phone No.: USA: +1 972-362 -8199/ +91 9665341414

Continued here:
Stem Cell Therapy Market Revenue, Key Players, Supply-Demand, Investment Feasibility and Forecast 2026 - The Think Curiouser

Read More...

Potential impact of Covid-19 on Rheumatoid Arthritis Stem Cell Therapy Market Growth and Demand, Concludes Fact.MR – The Cloud Tribune

October 23rd, 2020 2:57 pm

The globalRheumatoid Arthritis Stem Cell Therapy marketstudy presents an all in all compilation of the historical, current and future outlook of the market as well as the factors responsible for such a growth. With SWOT analysis, the business study highlights the strengths, weaknesses, opportunities and threats of each Rheumatoid Arthritis Stem Cell Therapy market player in a comprehensive way. Further, the Rheumatoid Arthritis Stem Cell Therapy market report emphasizes the adoption pattern of the Rheumatoid Arthritis Stem Cell Therapy across various industries.Request Sample Reporthttps://www.factmr.com/connectus/sample?flag=S&rep_id=1001The Rheumatoid Arthritis Stem Cell Therapy market report highlights the following players:The global market for rheumatoid arthritis stem cell therapy is highly fragmented. Examples of some of the key players operating in the global rheumatoid arthritis stem cell therapy market include Mesoblast Ltd., Roslin Cells, Regeneus Ltd, ReNeuron Group plc, International Stem Cell Corporation, TiGenix and others.

The Rheumatoid Arthritis Stem Cell Therapy market report examines the operating pattern of each player new product launches, partnerships, and acquisitions has been examined in detail.Important regions covered in the Rheumatoid Arthritis Stem Cell Therapy market report include:

North America (U.S., Canada)Latin America (Mexico, Brazil)Western Europe (Germany, Italy, U.K., Spain, France, Nordic countries, BENELUX)Eastern Europe (Russia, Poland, Rest Of Eastern Europe)Asia Pacific Excluding Japan (China, India, Australia & New Zealand)JapanMiddle East and Africa (GCC, S. Africa, Rest Of MEA)

The Rheumatoid Arthritis Stem Cell Therapy market report takes into consideration the following segments by treatment type:

Allogeneic Mesenchymal stem cellsBone marrow TransplantAdipose Tissue Stem Cells

The Rheumatoid Arthritis Stem Cell Therapy market report contain the following distribution channel:

HospitalsAmbulatory Surgical CentersSpecialty ClinicsHave Any Query? Ask our Industry Experts-https://www.factmr.com/connectus/sample?flag=AE&rep_id=1001

Buy the report at a discounted rate!!! Exclusive offer!!!

The Rheumatoid Arthritis Stem Cell Therapy market report offers a plethora of insights which include:

Changing consumption pattern among individuals globally.Historical and future progress of the global Rheumatoid Arthritis Stem Cell Therapy market.Region-wise and country-wise segmentation of the Rheumatoid Arthritis Stem Cell Therapy market to understand the revenue, and growth lookout in these areas.Accurate Year-on-Year growth of the global Rheumatoid Arthritis Stem Cell Therapy market.Important trends, including proprietary technologies, ecological conservation, and globalization affecting the global Rheumatoid Arthritis Stem Cell Therapy market.

The Rheumatoid Arthritis Stem Cell Therapy market report answers important questions which include:

Which regulatory authorities have granted approval to the application of Rheumatoid Arthritis Stem Cell Therapy in Health industry?How will the global Rheumatoid Arthritis Stem Cell Therapy market grow over the forecast period?Which end use industry is set to become the leading consumer of Rheumatoid Arthritis Stem Cell Therapy by 2028?What manufacturing techniques are involved in the production of the Rheumatoid Arthritis Stem Cell Therapy?Which regions are the Rheumatoid Arthritis Stem Cell Therapy market players targeting to channelize their production portfolio?Get Full Access of the Report @https://www.factmr.com/report/1001/rheumatoid-arthritis-stem-cell-therapy-market

Pertinent aspects this study on the Rheumatoid Arthritis Stem Cell Therapy market tries to answer exhaustively are:

What is the forecast size (revenue/volumes) of the most lucrative regional market? What is the share of the dominant product/technology segment in the Rheumatoid Arthritis Stem Cell Therapy market? What regions are likely to witness sizable investments in research and development funding? What are Covid 19 implication on Rheumatoid Arthritis Stem Cell Therapy market and learn how businesses can respond, manage and mitigate the risks? Which countries will be the next destination for industry leaders in order to tap new revenue streams? Which new regulations might cause disruption in industry sentiments in near future? Which is the share of the dominant end user? Which region is expected to rise at the most dominant growth rate? Which technologies will have massive impact of new avenues in the Rheumatoid Arthritis Stem Cell Therapy market? Which key end-use industry trends are expected to shape the growth prospects of the Rheumatoid Arthritis Stem Cell Therapy market? What factors will promote new entrants in the Rheumatoid Arthritis Stem Cell Therapy market? What is the degree of fragmentation in the Rheumatoid Arthritis Stem Cell Therapy market, and will it increase in coming years?Why Choose Fact.MR?

Fact.MR follows a multi- disciplinary approach to extract information about various industries. Our analysts perform thorough primary and secondary research to gather data associated with the market. With modern industrial and digitalization tools, we provide avant-garde business ideas to our clients. We address clients living in across parts of the world with our 24/7 service availability.

Originally posted here:
Potential impact of Covid-19 on Rheumatoid Arthritis Stem Cell Therapy Market Growth and Demand, Concludes Fact.MR - The Cloud Tribune

Read More...

Lucrative Opportunities in North America to Propel the Growth of the Amniotic Fluid Stem Cell Therapy Market 2018 2026 – TechnoWeekly

October 23rd, 2020 2:57 pm

Amniotic Fluid Stem Cell Therapy Market 2018: Global Industry Insights by Global Players, Regional Segmentation, Growth, Applications, Major Drivers, Value and Foreseen till 2024

The report provides both quantitative and qualitative information of global Amniotic Fluid Stem Cell Therapy market for period of 2018 to 2025. As per the analysis provided in the report, the global market of Amniotic Fluid Stem Cell Therapy is estimated to growth at a CAGR of _% during the forecast period 2018 to 2025 and is expected to rise to USD _ million/billion by the end of year 2025. In the year 2016, the global Amniotic Fluid Stem Cell Therapy market was valued at USD _ million/billion.

This research report based on Amniotic Fluid Stem Cell Therapy market and available with Market Study Report includes latest and upcoming industry trends in addition to the global spectrum of the Amniotic Fluid Stem Cell Therapy market that includes numerous regions. Likewise, the report also expands on intricate details pertaining to contributions by key players, demand and supply analysis as well as market share growth of the Amniotic Fluid Stem Cell Therapy industry.

Request Sample Report @ https://www.persistencemarketresearch.co/samples/23101

Amniotic Fluid Stem Cell Therapy Market Overview:

The Research projects that the Amniotic Fluid Stem Cell Therapy market size will grow from in 2018 to by 2024, at an estimated CAGR of XX%. The base year considered for the study is 2018, and the market size is projected from 2018 to 2024.

Leading manufacturers of Amniotic Fluid Stem Cell Therapy Market:

key players operating in global amniotic fluid stem cell therapy market are Stem Shot, Provia Laboratories LLC, Thermo Fisher Scientific Inc. Mesoblast Ltd., Roslin Cells, Regeneus Ltd. etc. among others.

The report covers exhaustive analysis on:

Regional analysis includes

Report Highlights:

Request Report Methodology @ https://www.persistencemarketresearch.co/methodology/23101

Some important highlights from the report include:

For any queries get in touch with Industry Expert @ https://www.persistencemarketresearch.co/ask-an-expert/23101

The Questions Answered by Amniotic Fluid Stem Cell Therapy Market Report:

And Many More.

See original here:
Lucrative Opportunities in North America to Propel the Growth of the Amniotic Fluid Stem Cell Therapy Market 2018 2026 - TechnoWeekly

Read More...

Global Adipose Derived Stem Cell Therapy Market 2020 Demand, Business Growing Strategies, Industry Segmentation and Forecast 2025 – TechnoWeekly

October 23rd, 2020 2:57 pm

An up-to-date intelligence study by Global Adipose Derived Stem Cell Therapy Market Growth (Status and Outlook) 2020-2025 provides the present scenario of the market and offers a comparative assessment of the market. The report provides historical data, significance, statistical data, size & share, market price & demand, business overview, market analysis by product and market trends by key players. It detects that the global Adipose Derived Stem Cell Therapy market by technological advancements and the presence of a large number of players, who are making the competitive landscape distributed. The report further highlights current growth factors, market threats, attentive opinions, and competitive analysis of major Adipose Derived Stem Cell Therapy market players, value chain analysis, and future roadmap.

Competitiveness:

The Adipose Derived Stem Cell Therapy market is fragmented and is characterized by the presence of key vendors and other prominent vendors. Key vendors are trying to maintain themselves in the global Adipose Derived Stem Cell Therapy market, whereas, regional vendors are focusing on product offerings to establish themselves in the market. Vendors are providing a different range of product lines intensifying the competitive scenario.

DOWNLOAD FREE SAMPLE REPORT: https://www.marketandresearch.biz/sample-request/150958

NOTE: Our analysts monitoring the situation across the globe explains that the market will generate remunerative prospects for producers post COVID-19 crisis. The report aims to provide an additional illustration of the latest scenario, economic slowdown, and COVID-19 impact on the overall industry.

Market Potential:

The market vendors have been forecasted to obtain new opportunities as there has been an increased emphasis on spending more on the work of research and development by many of the manufacturing companies. Additionally, many of the market participants are anticipated to make a foray into the emerging economies that are yet to be explored so as to find new opportunities. The global Adipose Derived Stem Cell Therapy market has gone through rapid business transformation by good customer relationships, drastic and competitive growth, significant changes within the market, and technological advancement in the worldwide market.

Topmost list manufacturers/ key player/ economy by business leaders leading players of the market are: AlloCure, Tissue Genesis, Antria, Cellleris, Corestem, Celgene Corporation, Mesoblast, Cytori Therapeutics, Pluristem Therapeutics, Intrexon, Lonza, BioRestorative Therapies, Pluristem Therapeutics, iXCells Biotechnologies, Cyagen, Celltex Therapeutics Corporation,

Geographically, this report studies market share and growth opportunity in the following key regions: Americas (United States, Canada, Mexico, Brazil), APAC (China, Japan, Korea, Southeast Asia, India, Australia), Europe (Germany, France, UK, Italy, Russia), Middle East & Africa (Egypt, South Africa, Israel, Turkey, GCC Countries)

On the basis of product segment, this report covers: Autologous Stem Cells, Allogeneic Stem Cells,

On the basis of Application segment, this report covers: Therapeutic Application, Research Application,

ACCESS FULL REPORT: https://www.marketandresearch.biz/report/150958/global-adipose-derived-stem-cell-therapy-market-growth-status-and-outlook-2020-2025

Important Take-Away:

Moreover, the report has covered the PEST analysis by region and key economies across the globe, PORTERs analysis, and detailed SWOT analysis of key players to analyze their strategies. It guides companies to make effective business strategy decisions by knowing the global Adipose Derived Stem Cell Therapy market conditions and sentiment within the market. The report serves to adjust investment allocation by outlining key focus areas of the industry.

Customization of the Report:This report can be customized to meet the clients requirements. Please connect with our sales team ([emailprotected]), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

About Us

Marketandresearch.biz is a leading global Market Research agency providing expert research solutions, trusted by the best. We understand the importance of knowing what global consumers watch and buy, further using the same to document our distinguished research reports. Marketandresearch.biz has worldwide presence to facilitate real market intelligence using latest methodology, best-in-class research techniques and cost-effective measures for worlds leading research professionals and agencies. We study consumers in more than 100 countries to give you the most complete view of trends and habits worldwide. Marketsandresearch.biz is a leading provider of Full-Service Research, Global Project Management, Market Research Operations and Online Panel Services.

Contact UsMark StoneHead of Business DevelopmentPhone: +1-201-465-4211Email: [emailprotected]Web: http://www.marketandresearch.biz

Other Related Reports Here:

Global Myristamine Oxide Market 2020 Industry Growth Analysis by Key Players, Segments, Competitive Landscape and Forecast to 2026

Global Rivastigmine Tartrate Market 2020 Emerging Trend, Top Companies, Industry Demand, Business Review and Regional Analysis by 2026

Global 3-Methoxy-3-Methyl-1-Butanol Market 2020 Industry Status and Outlook, Competitive Landscape and Growth by 2026

Global Sodium Tetra Sulphide Market 2020 Industry Analysis, Size, Share, Growth, Trend and Forecast to 2026

Global 3-Chloropivaloyl Chloride Market 2020 by Key Players, Regions, Type and Application, Forecast to 2026

Continued here:
Global Adipose Derived Stem Cell Therapy Market 2020 Demand, Business Growing Strategies, Industry Segmentation and Forecast 2025 - TechnoWeekly

Read More...

Otilimab Well Tolerated and May Improve Synovitis in Active Rheumatoid Arthritis – Rheumatology Advisor

October 23rd, 2020 2:56 pm

Treatment with otilimab, a monoclonal antibody that inhibits granulocyte-macrophage colony-stimulating factor (GM-CSF), is well tolerated, despite optimal exposure, and may improve synovitis in patients with active rheumatoid arthritis (RA), according to study results published in Lancet Rheumatology.

Previous studies have reported that GM-CSF can act as a proinflammatory cytokine and has an important role in a broad range of immune-mediated conditions, making it a valuable therapeutic target in patients with RA. The objective of the current mechanistic phase 2a study was to determine the effect of otilimab on the GM-CSF-chemokine (C-C motif) ligand 17 (CCL17) axis and synovitis in patients with RA.

The multicenter, randomized, placebo-controlled study (ClinicalTrials.gov Identifier: NCT02799472) included adult patients with RA from across 9 sites in the United States, Poland, and Germany. Participants were randomly assigned to receive either 180 mg of subcutaneous otilimab or placebo. The primary outcome was change over time in 112 biomarkers. Secondary end points included change from baseline in synovitis, osteitis, and erosion assessed by the RA magnetic resonance imaging (MRI) Scoring (RAMRIS) system, RA MRI Quantitative (RAMRIQ) score, and safety evaluation.

A total of 39 patients with RA who were randomly assigned to receive otilimab (n=28) or placebo (n=11) were included in the final cohort. Weekly subcutaneous injections of otilimab 180 mg or placebo were administered for 5 weeks, then every other week until week 10, followed by a 12-week safety follow-up.

Results showed that mean serum concentrations of the GM-CSF-otilimab complex peaked at week 4 (138.4 ng/L), but reduced from week 6 to 12, with CCL17 concentrations decreasing and then returning to baseline at week 12 (least-squares mean ratios at weeks 2, 4, 6, and 8 were 0.65, 0.68, 0.78, and 0.68, respectively). In the placebo group, no significant changes in CCL17 concentrations were noted. There were also no differences between groups for all other biomarkers.

Results from imaging measures of synovitis showed a reduction from baseline to week 12 in patients who received otilimab. Differences in MRI outcomes were minimal, and a trend for reduced synovitis and osteitis was seen early during active treatment, but not at 12 weeks after the treatment was stopped. The RAMRIS synovitis score showed a least-squares mean change from baseline of -1.3 (SE, 0.6) in the otilimab group and a mean change of 0.8 (SE, 1.2) in the placebo group (P =.11). The RAMRIQ synovitis score showed a least-squares mean change from baseline of -1417.0 L in the otilimab group and -912.3 L with placebo (P =.75).

All adverse events were reported to be mild or moderate, and the number of adverse events was similar in the otilimab and placebo groups (39% and 36%, respectively). The most common adverse event was cough (7%) in the active treatment group and pain in extremity (18%) and RA (18%) in the placebo group. There were no serious adverse events or deaths.

The study had several limitations, including the relatively small sample size, imbalanced baseline disease-modifying antirheumatic drug use among treatment groups, and the determination of the RAMRIS synovitis score based on assessment by a single radiologist.

The findings of this study support the rationale for the further clinical development of otilimab as a treatment option for patients with [RA]. Additionally, the effect of otilimab on CCL17 indicates that CCL17 shows promise as a pharmacodynamic biomarker for otilimab in future studies, the researchers concluded.

Disclosure: This clinical trial was supported by GlaxoSmithKline. Please see the original reference for a full list of authors disclosures.

Genovese MC, Berkowitz M, Conaghan PG, et al. MRI of the joint and evaluation of the granulocytemacrophage colony-stimulating factorCCL17 axis in patients with rheumatoid arthritis receiving otilimab: a phase 2a randomised mechanistic study. Lancet Rheumatol. Published online October 7, 2020. doi:10.1016/s2665-9913(20)30224-1

Excerpt from:
Otilimab Well Tolerated and May Improve Synovitis in Active Rheumatoid Arthritis - Rheumatology Advisor

Read More...

Page 366«..1020..365366367368..380390..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick